Mutual Regulation of CRP and N(epsilon)-Lysine Acetylation in Escherichia Coli by Davis, Robert James
Loyola University Chicago 
Loyola eCommons 
Dissertations Theses and Dissertations 
2017 
Mutual Regulation of CRP and N(epsilon)-Lysine Acetylation in 
Escherichia Coli 
Robert James Davis 
Loyola University Chicago 
Follow this and additional works at: https://ecommons.luc.edu/luc_diss 
 Part of the Microbiology Commons 
Recommended Citation 
Davis, Robert James, "Mutual Regulation of CRP and N(epsilon)-Lysine Acetylation in Escherichia Coli" 
(2017). Dissertations. 2792. 
https://ecommons.luc.edu/luc_diss/2792 
This Dissertation is brought to you for free and open access by the Theses and Dissertations at Loyola eCommons. 
It has been accepted for inclusion in Dissertations by an authorized administrator of Loyola eCommons. For more 
information, please contact ecommons@luc.edu. 
Copyright © 2017 Robert James Davis 
 
 
LOYOLA UNIVERSITY CHICAGO 
 
MUTUAL REGULATION OF CRP AND Nε-LYSINE ACETYLATION IN ESCHERICHIA COLI 
 
A DISSERTATION SUBMITTED TO 
THE FACULTY OF THE GRADUATE SCHOOL 
IN CANDIDACY FOR THE DEGREE OF 
DOCTOR OF PHILOSOPHY 
 
PROGRAM IN BIOCHEMISTRY AND MOLECULAR BIOLOGY 
 
BY 
ROBERT JAMES DAVIS 
CHICAGO, IL 
DECEMBER 2017
 
 
Copyright by Robert James Davis, 2017 
All rights reserved.
iii 
 
ACKNOWLEDGEMENTS 
 I would like to thank my mentor, Dr. Alan Wolfe, for his guidance during my time at 
Loyola. He encouraged me to think deeply about science, taught me to become a better writer, 
and provided emotional support when I needed it. I would like to thank Dr. Mitchell Denning, 
my committee chair, for accepting me into the Molecular Biology program and guiding me 
through the academic side of graduate school. I would like to thank Dr. Karen Visick, who 
provided insightful discussions during lab meetings. I would like to thank Dr. Richard Schultz, 
who often provided interesting conversation, even when not directly related to my project. I 
would like to thank Dr. Adam Driks, whose constructive criticisms were invaluable for honing 
my presentation skills. I would also like to thank Dr. Francis Alonzo, who graciously stepped in 
at the last minute to round out my dissertation committee. 
 I would like to thank my family, who supported me both emotionally and financially 
throughout my entire education. I am very lucky to have loving parents who worked hard to 
ensure their children had every available opportunity. I would like to thank the friends I made 
at Loyola, who provided much needed relief from the stresses of graduate school. Finally, I 
would like to thank my future spouse, Cory. I cannot thank her enough for her patience and 
support during my time in graduate school. I don’t think I would have had the strength to 
complete my degree without her, which is one of a million reasons I will always love her.
 
 
For Cory, who provides a never-ending supply of motivation, inspiration, and love.
v 
 
TABLE OF CONTENTS 
ACKNOWLEDGEMENTS iii 
LIST OF TABLES vii 
LIST OF FIGURES viii 
LIST OF ABBREVIATIONS x 
ABSTRACT xi  
CHAPTER ONE: INTRODUCTION  
   Introduction 1 
   Transcription 2 
   Transcriptional Regulation 4 
   cAMP Receptor Protein (CRP) 8 
      Regulation of Transcription by CRP 8 
      Regulation of CRP Expression 13 
   Catabolite Repression 14 
   Overflow Metabolism 19 
   Protein Acetylation 25 
      Nα-Acetylation 26 
      Nε-Lysine Acetylation 27 
      O-Acetylation 33 
   Summary 34 
 
CHAPTER TWO: MATERIALS AND METHODS  
   Bacterial Strains, Plasmids, and Primers 36 
   Culture Conditions 36 
   Generalized P1 Transduction 37 
   Plasmid Construction 37 
   Site-Directed Mutagenesis 38 
   Transformation 38 
      TBF 38 
      TSS 39 
      Electroporation 40 
   CRP Expression and Purification 40 
   In Vitro Transcription 41 
   qRT-PCR 43 
   Western Immunoblot Analysis 44 
   Promoter Activity Assays 46 
   Model Characterization 46 
   Motility Assays 47 
vi 
 
   In Vitro Acetylation 47 
   Quantitative Mass Spectrometry 48 
   Protein Identification and Quantification 49 
   RNAseq 50 
   DNA Microarray 51 
   CRP Stability Assay 52 
 
CHAPTER THREE: RESULTS  
   Regulation of Acetylation by CRP 57 
   CRP-Dependent Regulation of yfiQ Transcription 57 
   CRP-Dependent Regulation of Glucose-Induced Acetylation 61 
   Summary 65 
 
CHAPTER FOUR: RESULTS 
   Regulation of CRP by Acetylation 66 
   The Role of the K100 Positive Charge at Class II and Class I Promoters 67 
   Interaction Between K100 and RNAP α Subunit NTD 72 
   The Role of the K100 Positive Charge in Global Transcription 77 
      CRP Overexpression in a Complex Media 77 
      Single Copy Chromosomal Expression of crp in Minimal Media 81 
   Pathway Enrichment Analysis of K100-Regulated Genes 85 
   K100 Regulates Flagellar-Based Motility 87 
   K100 is Acetylated by AcP In Vitro 89 
   Stability of K100 and K101 Mutants 96 
   Identification of Proteins Involved in CRP Degradation 100 
   Summary 106 
 
CHAPTER FIVE: DISCUSSION 
   CRP Regulation of Acetylation 108 
   Use of K100 Acetyllysine Mimics 110 
   Function of K100 Acetylation 111 
   K100 Acetylation and Flagellar Motility 115 
   Stoichiometry of K100 Acetylation 117 
   Acetylation of CRP K26 122 
   CRP Stability 123 
   CRP Degradation 125 
   Concluding Remarks 126 
 
REFERENCE LIST 128 
VITA 152 
vii 
 
LIST OF TABLES 
Table 1. Strains, phage, plasmids, and primers 54 
Table 2. Number of genes and promoters whose regulation was significantly altered  
   by the K100 charge status 79 
  
Table 3. DAVID analysis of genes significantly altered by the K100 charge status 86 
Table 4. Quantification of increases in CRP acetylation after incubation with acP 94 
Table 5. Quantification of increases in CRP abundance after incubation with acP 95 
viii 
 
LIST OF FIGURES 
Figure 1. CRP-RNAP interactions at Class I and Class II promoters 10 
Figure 2. Crystal structure of CRP 11 
Figure 3. The phosphotransferase system 16 
Figure 4. Catabolite repression/inducer exclusion 17 
Figure 5. Glycolysis and the TCA cycle 21 
Figure 6. The acetate activation pathway 24 
Figure 7. Nε-lysine acetylation 28 
Figure 8. Transcription of yfiQ requires CRP 59  
Figure 9. Epistasis between CRP and acP regarding glucose-induced acetylation 63  
 
Figure 10. Quantification of CRP steady state levels 69 
Figure 11. Effect of K100 positive charge on Class II promoter activity 71 
Figure 12. Effect of K100 positive charge on Class I promoter activity 73  
Figure 13. Determination of the independence of the K100 positive charge from K101 74 
Figure 14. Model of the interaction between K100 and RNAP at a Class II promoter 76 
Figure 15. K100-mediated regulation of motility 90 
Figure 16. CRP acetylation by acP in vitro 92 
Figure 17. Analysis of K100 acetylation in vitro 93 
Figure 18. Quantification of crp mRNA 98 
Figure 19. Stability of CRP variants 99
ix 
 
Figure 20. Role of K100 positive charge in DnaJ-mediated CRP stability 102 
Figure 21. Determination of proteins involved in CRP degradation 105
x 
 
LIST OF ABBREVIATIONS 
RNAP RNA polymerase 
TSS Transcription start site 
CTD/NTD C-terminal domain/N-terminal domain 
TF Transcription factor 
cAMP Cyclic AMP 
CRP cAMP receptor protein 
HTH Helix-turn-helix 
AR Activating region 
PTS Phosphotransferase system 
TCA Tricarboxylic acid cycle 
TCST Two component signal transduction 
NAT N-acetyltransferase 
KAT Lysine acetyltransferase 
KDAC Lysine deacetylase 
acCoA Acetyl CoA 
acP Acetyl phosphate 
VC Vector control 
WT Wild type 
TB7 Tryptone broth pH 7 
xi 
 
ABSTRACT 
Post-translational modifications, such as Nε-lysine acetylation, are known to alter the 
behavior of transcriptional regulators in eukaryotes, but very little is known about the 
consequences of acetylation on transcriptional regulation in bacteria. Here, I provide evidence 
that a global transcriptional regulator of carbon metabolism, cAMP Receptor Protein (CRP), 
promotes both enzymatic and non-enzymatic lysine acetylation in E. coli. Non-enzymatic lysine 
acetylation occurs when cells ferment acetate, such as during growth on high concentrations of 
glucose. Intriguingly, CRP can be non-enzymatically acetylated on several lysines, including 
lysine 100 (K100). I provide evidence that neutralization of the K100 positive charge, as would 
occur upon K100 acetylation, has a dual effect on CRP activity. First, K100 neutralization 
decreases CRP activity at some Class II promoters. This decreased activity likely results from 
disruption of the interaction between Activating Region 2 (AR2) of CRP and the RNA polymerase 
α subunit N-terminal domain. Second, K100 neutralization increases the CRP half-life, leading to 
increased CRP steady state levels. Due to increased steady state levels, CRP activity is increased 
at some Class I promoters, in which CRP does not require AR2. Taken together, I propose that 
CRP promotes global acetylation, including CRP K100 acetylation, when cells are grown on 
glucose by positively regulating non-enzymatic acetylation. A consequence of K100 acetylation 
may be inverse regulation of Class II and Class I promoters under these conditions. This 
mechanism may help regulate carbon flux though central metabolism. 
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CHAPTER ONE 
INTRODUCTION 
 
Introduction 
 Bacteria can be found thriving almost everywhere in nature. To do so, they must be able 
to monitor their environment, both extracellular and intracellular, and alter their behavior in 
response to changes in their environment. For example, if there is a lack of nutrients in the 
immediate vicinity, a bacterium must move itself to a new location with greater nutrient 
availability, or limit its growth and energy expenditure until nutrients become available. 
 Bacterial behavior is governed in part by the proteins that are expressed within the cell. 
The cell must control the timing of the synthesis and degradation of each protein to ensure the 
correct behaviors are active at the right time. To this end, the cell encodes hundreds of 
transcription factors, which are responsible for regulating the expression of different subsets of 
genes. Some of these transcription factors are directly sensitive to the environment, becoming 
activated or inactivated through direct interaction with small molecules, such as oxygen, 
nitrogen, or carbon sources. Other transcription factors respond to changes in the environment 
through post-translational modifications: covalent modifications to proteins that often alter 
their activity. These post-translational modifications are indirect environmental signals, often 
passed down by proteins that more directly sense environmental cues. 
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This dissertation investigates a novel relationship between transcriptional regulation 
and post-translational modification. There is evidence that the global transcription factor CRP 
enhances the abundance of Nε-lysine acetylation throughout the cell, altering the activities of 
the modified proteins. Furthermore, CRP itself is modified by Nε-lysine acetylation, and 
therefore its activity may be affected by Nε-lysine acetylation. The work presented in this 
document is aimed at investigating the mechanisms by which CRP influences Nε-lysine 
acetylation and vice versa. 
 To better understand the rationale and data presented in this dissertation, I will begin 
by describing the process of transcription. I will then describe the regulation of transcription, 
first generally and then with a specific focus on CRP. Next, I will discuss catabolite repression 
and overflow metabolism, both of which are mechanisms the cell uses to alter its metabolism 
when sufficient glucose is available. Finally, I will go into detail about the various types of 
protein acetylation and their effects on protein function, with a specific focus on Nε-lysine 
acetylation. 
 
Transcription 
 Transcription is the process of generating RNA from a DNA template. In bacteria, 
transcription is performed by a single complex of proteins called RNA polymerase (RNAP) (1, 2). 
The RNAP core complex is made up of five subunits: α (x2), β, β’, and ω. These five subunits are 
highly conserved across all domains of life and are sufficient for RNA synthesis; however, 
another subunit, σ, is required to bind to the RNAP core complex to direct the assembled RNAP 
to specific promoters. This RNAP-σ complex is called the RNAP holoenzyme. Binding of the 
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RNAP holoenzyme to DNA results in the formation of what has been termed the closed 
complex. In most cases, conformational changes (isomerization) within the RNAP holoenzyme 
provide the energy required to melt and unwind the promoter DNA, which forms the open 
complex. Once transcription begins, the first few ribonucleotides are ligated together within the 
initiation complex. At this point, the RNAP holoenzyme is still anchored to the promoter DNA 
via σ. Instead of moving forward down the DNA strand to synthesize RNA, RNAP pulls the DNA 
into itself, which has a two-fold effect. First, it allows for the synthesis of a short (9-11 
nucleotides) initial fragment of RNA. Second, the DNA pulled into RNAP “scrunches”, providing 
energy to allow RNAP to escape the promoter (3). In many cases, the DNA “slips” out of RNAP, 
causing a loss of the accumulated energy and release of the initial fragment of RNA, called an 
abortive transcript. If abortive transcription occurs, RNAP reverts to an open complex 
conformation and attempts to initiate transcription again. Upon successful initiation of 
transcription, RNAP uses the energy stored in the “scrunched” DNA to escape the promoter by 
dissociating from σ, forming the elongation complex, and continuing RNA synthesis from the 
initial fragment. 
There are seven known σ factors in E. coli, six of which belong to the σ70 family of σ 
factors (4, 5). The seventh σ factor, σ54, is structurally and functionally distinct from the σ70 
family members and will not be discussed here (6). Each σ factor is comprised of four conserved 
major domains (regions 1-4), and each major domain can be broken down into minor domains. 
Although each σ factor recognizes a consensus sequence that is specific for that σ factor, there 
is some tolerance for degenerate sequences, which allows the cell to control the probability 
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and strength of the RNAP holoenzyme interaction with the promoter. Additionally, this 
tolerance can result in an overlap in the regulons of σ factors (7, 8).  
 The RNAP holoenzyme makes several contacts with nucleotide sequences within 
promoter DNA to ensure transcription begins at the correct location (1). The primary sequences 
that regulate σ factor specificity are called the -35 and -10 elements, since the sequences are 
located approximately 35 and 10 nucleotides upstream of the transcription start site (TSS) 
respectively. The -35 element interacts with σ region 4.2, and the -10 element interacts with σ 
region 2.4. A third contact is made between the promoter DNA and the spacer region between 
σ regions 2.4 and 3.1 (referred to as either region 2.5 or 3.0) when an extended -10 element is 
present in the promoter (9, 10). The extended -10 element is a two-nucleotide sequence 
located just upstream of the -10 element, and is generally present only when the -35 element is 
absent.  
 In addition to the contacts made between σ and the promoter DNA, the C-terminal 
domain (CTD) of the RNAP α subunit also contacts the promoter DNA at sequences called UP 
elements (11). These sequences are located upstream of the -35 element and are rich in 
adenosines (A) and thymidines (T). Binding of the α-CTD to the UP element provides an 
additional point for promoter recognition and stabilization of the RNAP closed complex. 
 
Transcriptional Regulation 
There are currently 4627 recognized genes in Escherichia coli (12). To ensure the proper 
timing and level of expression for each gene, the regulation of transcription must be tightly 
controlled. There are several layers of transcriptional regulation; some of which are hardwired 
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into the DNA (cis-acting), while others can respond to changes in the external or internal 
environment (trans-acting). Together these layers of regulation allow fine-tuning of gene 
transcription based on the changing needs of the cell. 
In bacteria, genes are often organized in groups called operons. Genes within an operon 
generally encode proteins that perform similar functions or operate within similar pathways. At 
the most simplistic level, genes within an operon are transcribed together from a single 
promoter into a single messenger RNA (mRNA) transcript, and are therefore all under the same 
transcriptional regulation. This allows for efficient expression of many or all of the genes 
required for a particular function with minimal coordination required. Many operons have 
additional complexities, including internal promoters, to fine-tune the expression of genes 
within the operon. This means that while a single mRNA can encode all the genes of an operon 
under certain conditions, other conditions may favor separating transcription of the operon 
into multiple mRNAs. 
  There are approximately 300 DNA binding proteins that can bind to promoter DNA and 
regulate transcription (13). The majority of these DNA binding proteins fall into the category of 
transcription factors (TFs), which directly impact the recruitment or isomerization of RNAP. 
Much like the RNAP holoenzyme, TFs interact with the DNA at specific binding sites unique for 
each TF. By analyzing all known binding sites for a particular TF, a consensus sequence can be 
obtained that represents the sequence for which the TF has highest affinity. Deviation from the 
consensus sequence allows the cell to control the affinity a TF has for a particular binding site, 
allowing a more nuanced regulation of transcription initiation. Relatively weak affinity of a TF 
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for its binding site can be enhanced through interactions with other TFs, helping to keep a 
promoter turned off until the right conditions are met. 
 TFs regulate RNAP activity by two broad mechanisms: inhibition and activation. Many, 
but not all, TFs can act as either an inhibitor or an activator depending on the context of the 
promoter. Modes of transcriptional inhibition can be sorted into three categories. The first is 
repression by steric hindrance. This type of repression occurs when the TF binds at a site in the 
promoter that is very near or overlapping the RNAP binding site, preventing RNAP from binding. 
This is one of the mechanisms used by the lac operon repressor LacI (14). The second mode of 
repression is by DNA looping. This type of repression occurs when one or more TFs bind to 
multiple sites around the promoter. These TFs then interact with each other, causing the DNA 
to bend and form a loop around the promoter, preventing access to RNAP. This mechanism is 
used by GalR to repress the gal operon (15), and by LacI to enhance its repression of the lac 
operon (16). The third mode of repression is by disrupting the activity of an activator, or anti-
activation. At the deoP2 promoter, two CRP dimers bind to separate locations and activate 
transcription of the deo operon. The CytR repressor is capable of binding between the two CRP 
dimers and interacting with the promoter-proximal dimer, resulting in repression of deo 
transcription. The proposed mechanism involves a CytR-induced conformational change within 
CRP, preventing CRP-induced activation of deo transcription (17). 
 As with transcriptional repression, there are three categories of transcriptional 
activation. The first two categories operate through direct interaction with RNAP. Class I 
activation involves interaction between a TF and the RNAP α subunit CTD. This interaction aids 
in the recruitment of RNAP to the promoter and formation of the closed complex, usually in 
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cases where the RNAP binding site is weak (18, 19). Several activators employ this mechanism, 
including Ada at the ada promoter (20), OmpR at the ompC promoter (21), OxyR at the katG 
and ahpC promoters (22), and CRP at the uxuAB and lac promoters (23). Class II activation 
involves interaction between a TF and other regions of RNAP, generally the α subunit NTD or σ 
subunit. Unlike Class I activation, Class II activation primarily promotes the isomerization of 
RNAP from the closed to open complex (18). Examples of Class II activators include cI of the λ 
bacteriophage at the λPRM promoter, which interacts with σ subunit region 4 (24), and CRP at 
the galP1 promoter, which interacts with the α subunit NTD (25). The third category of 
transcriptional activation involves distorting the DNA to enhance RNAP binding. At the soxS 
promoter, there are 19 base pairs in the space between the -10 and -35 regions of the RNAP 
binding site instead of the ideal 17 ± 1 base pairs, preventing efficient RNAP binding. SoxR binds 
in the space between the -10 and -35 regions and twists the DNA, bringing the -10 and -35 
regions closer together to allow RNAP binding. SoxR binding occurs on the opposite side of the 
DNA, allowing SoxR and RNAP to bind simultaneously (26, 27). 
 Almost half of all TFs are directly activated or inhibited by small molecules (28). For 
example, LacI becomes inactivated upon binding to allolactose, relieving repression of the lac 
operon, which encodes the genes required for the transport and metabolism of lactose (29). 
Fumarate and nitrate reductase (FNR) becomes inactivated through interaction with O2, 
preventing expression of genes involved with anaerobic metabolism (30). Not all small molecule 
interactions inactivate TFs. Melibiose binding activates MelR, which activates transcription of 
genes involved in melibiose metabolism (31). Direct regulation by small molecules allows TFs to 
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sense the environmental or nutritional status of the cell, and in turn alter gene expression to 
mount an appropriate response. 
 
cAMP Receptor Protein (CRP) 
CRP (also known as catabolite activator protein [CAP]) is one of seven global TFs that 
together regulate transcription of over 50% of the E. coli genome (32). Alone, CRP directly 
regulates the transcription of 430 genes, or almost 10% of the genome (12). The CRP regulon 
primarily consists of genes involved in the catabolism of secondary carbon sources (see Chapter 
One – Catabolite Repression), including most famously the lac operon (33). However, CRP 
regulates genes involved in a wide variety of other pathways as well. These pathways include 
biofilm formation (34), translation (35), persistence (36), antibiotic resistance (37), and 
virulence (38). In addition, CRP regulates the transcription of genes encoding other 
transcriptional regulators (39–42) and sigma factors (43, 44), allowing CRP to indirectly 
influence the transcription of genes well outside of its own regulon. Altogether, the evidence 
suggests that the influence of CRP is wide-reaching and impacts nearly every aspect of the cell. 
Regulation of Transcription by CRP 
 CRP is a dimer consisting of two identical monomers (45). Each monomer is made up of 
two domains: a large NTD and a smaller CTD. The CRP NTD (residues 1-133) is responsible for 
binding cyclic AMP (cAMP) and dimerization, while the CTD (residues 139-209) contains a helix-
turn-helix (HTH) motif that is responsible for DNA binding. These two domains are connected by 
a short flexible hinge region (residues 134-138). In the absence of cAMP, the DNA recognition 
helices within the HTH motifs are buried within the CRP dimer (46, 47). Upon binding cAMP, 
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structural changes within CRP cause the DNA recognition helices to swing out, allowing access 
to promoter DNA. These DNA recognition helices insert into two consecutive major grooves in 
the DNA at the CRP binding site, making both specific and non-specific interactions with the 
DNA (48). 
 CRP activates transcription primarily through direct interaction with RNAP. The 
interactions made between CRP and RNAP depend on the distance between the CRP and RNAP 
binding sites (Fig. 1). At Class I promoters, the CRP binding site is centered around 61.5, 71.5, 
82.5, or 92.5 nucleotides upstream of the TSS. The spacing between potential CRP binding sites 
is consistent with one complete turn of DNA (49), highlighting the fact that CRP is required to 
bind on the same face of the DNA as RNAP for productive interaction (50). The interaction 
between CRP and RNAP requires surface-exposed residues on each complex. On CRP, the 
critical residues are 156-164, also known as activating region 1 (AR1) (51) (Fig. 2). Although 
each CRP monomer contains an AR1, it is AR1 on the promoter-proximal monomer that is 
required at Class I promoters (52, 53). AR1 is located within a surface loop in the CRP CTD, 
though not near the HTH motif required for DNA binding. Residues within AR1 interact with 
residues 285-288 and 317 (also known as the 287 determinant) within the RNAP α subunit CTD 
(54). This interaction promotes the recruitment and stabilization of the RNAP closed complex 
(18). 
 At Class II promoters, CRP binds directly upstream of RNAP at a site centered around 
41.5 nucleotides upstream of the TSS. Like at Class I promoters, there is a productive 
interaction between CRP AR1 and the RNAP 287 determinant at some, but not all, Class II 
promoters (55, 56). At these promoters, it appears that the RNAP α subunit CTD extends over  
10 
 
 
 
  
CR
P 
CR
P 
CR
P 
CR
P 
σ 
σ 
α‐NTD 
α‐NTD 
α‐CTD 
α‐CTD 
Figure 1. CRP-RNAP interactions at Class I and Class II promoters. (Top) At Class I promoters, CRP 
binds around 60.5, 70.5, 81.5, or 91.5 nucleotides upstream of the transcription start site (TSS). CRP 
AR1 interacts with the RNAP α subunit C‐terminal domain (CTD). (Bottom) At Class II promoters, CRP 
binds around 41.5 nucleotides upstream of the TSS. CRP AR2 interacts with the RNAP α subunit N‐
terminal domain (NTD). The CRP AR1‐RNAP α subunit CTD interaction also occurs at some, but not all, 
Class II promoters. CRP AR3 interacts with the RNAP σ subunit, although this interaction is not 
considered to be significant. This figure was adapted from (236). 
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K101 K100 
H21 
E96 
H19 
AR2 
AR1 
Figure 2. Crystal structure of CRP. A cAMP-bound CRP homodimer (dark grey and light grey) is seen 
bound to DNA (thin lines). Residues that make up the three activating regions are highlighted in green 
(AR1), blue (AR2), and purple (AR3). Lysines which have been detected as acetylated are shown in tan. 
K101, shown in light blue, and K52, shown in light purple, are both acetylated and components of AR2 
and AR3 respectively. K100, a subject of this dissertation, is shown in red. The structure was 
determined by x-ray diffraction at a resolution of 3 angstroms (59). Figure was generated in Swiss-
PdbViewer 4.1.0. (PDB: 1CGP) 
AR3 
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the CRP dimer and interacts with AR1 of the promoter-distal monomer (53). However, the 
critical interaction between CRP and RNAP involves residues H19, H21, E96, and K101 (AR2) of 
CRP (Fig. 2) and residues E162, E163, D164, and E165 of the RNAP α subunit NTD (25). The 
positively charged residues of AR2 form ionic bonds with the negatively charged residues of the 
RNAP α subunit NTD, which primarily promotes the isomerization of the RNAP closed complex 
to the open complex (18). The negatively charged E96 residue has a small inhibitory effect on 
Class II transcription activation (25). 
 A third surface on CRP, AR3, can interact with the RNAP σ subunit region 4 at Class II 
promoters (57). AR3 is composed of an activating determinant consisting of residues D53, E54, 
E55, and E58, and an inhibitory determinant consisting of residue K52 (58). The negatively 
charged activating determinant interacts with positively charged residues K593, K597, and R599 
within the RNAP σ subunit to promote the isomerization of the RNAP closed complex to the 
open complex at Class II promoters, much like the AR2-RNAP α subunit NTD interaction (57, 
58). The positively charged inhibitory determinant likely clashes with the same positively 
charged RNAP σ subunit surface, disfavoring the AR3-RNAP σ subunit interaction (58). 
Interestingly, mutation of all AR3 residues to alanine results in nearly WT CRP activity at Class II 
promoters, suggesting the contributions of the activating and inhibitory determinants to 
promoter activation negate each other. Therefore, AR1 and AR2 are considered to be the only 
significant interactions between CRP and RNAP at Class II promoters. 
 In addition to making direct contact with RNAP, CRP regulates transcription by bending 
the surrounding DNA. Positively charged residues on the sides of the CRP dimer opposite the 
dimerization domains interact non-specifically with the negative phosphate groups in DNA, 
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causing the DNA to partially wrap around the CRP dimer. As a result, the DNA is bent 
approximately 80° around CRP (59–61) . This bend can bring relatively distant transcriptional 
regulators closer to RNAP, or it can prevent RNAP from binding to the promoter.  
Regulation of CRP Expression 
 As one of the seven global regulators that control the transcription of half of the 
genome (32), it is not surprising that the regulation of CRP expression is complex. In this 
section, I will describe in detail the regulators that are responsible for this pattern of 
expression, including regulators of crp transcription and CRP stability. 
 Transcription of the crp gene occurs from two different promoters: crp1 and crp2, 
located approximately 79 base pairs downstream of crp1 (62). In vivo, the majority of crp 
transcription comes from the crp1 promoter. There are two CRP binding sites within the crp 
promoter region, indicating that crp transcription is autoregulated (63). The first CRP site is 
centered 60.5 nucleotides upstream of crp1 (139.5 nucleotides upstream of crp2) and promotes 
crp transcription, indicating that crp1 is a Class I promoter (64). The second CRP site is centered 
41.5 nucleotides downstream of crp1 (37.5 nucleotides upstream of crp2) and inhibits crp 
transcription by recruiting RNAP to initiate transcription in the opposite direction from a 
divergent promoter (63, 65). In vivo, CRP predominately inhibits crp transcription; β-
galactosidase activity from a crp’-lacZ promoter fusion is increased in stains lacking crp relative 
to strains that express crp (62, 66). 
 Transcription of crp is regulated by two other transcription factors, Cra and Fis. Little is 
known about the role of Cra in crp transcription, except that Cra activates crp transcription by a 
mechanism that requires CRP (67). Fis inhibits crp transcription by binding to the promoter and 
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overlapping the RNAP binding sites (62). Fis levels are high at the beginning of growth (68), 
repressing the transcription of both crp and the divergent gene (62). As Fis levels begin to 
decline over growth, the divergent promoter, but not the crp promoter, becomes available for 
RNAP to initiate transcription and maintain the repression of crp. Once Fis levels are at a 
minimum in stationary phase, Fis is no longer bound to the crp promoter and crp transcription 
increases. As an added complexity, CRP regulates Fis expression, leading to cyclical regulatory 
crosstalk between the two regulators (41). 
 
Catabolite Repression 
Bacteria utilize a variety of carbon sources for growth and energy production. While the 
bacteria will eventually use all available carbon sources, most species have a preferred order in 
which they use the carbon sources based on how readily the carbon sources can be catabolized. 
This hierarchy of carbon preference is maintained through a process called catabolite 
repression (69), which will be discussed in this section. 
 Catabolite repression was first formally identified when it was observed that E. coli, 
when grown in a medium with both glucose and lactose as carbon sources, will grow by 
exclusively consuming glucose until the glucose is depleted, pause growth, then resume growth 
by consuming lactose (70). This phenomenon became known as the “glucose-lactose diauxie”. 
Other “preferred” carbohydrates were identified as being able to repress the ability of E. coli to 
simultaneously consume “secondary” carbohydrates, but since glucose has been the best 
studied, this section will focus on glucose as the preferred carbohydrate.  
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 The division of carbohydrates into “preferred” and “secondary” groups is primarily 
achieved by a transport system called the phosphotransferase system (PTS) (71, 72). The PTS is 
responsible for both repressing the expression of genes required for the catabolism of 
secondary carbohydrates and inhibiting the uptake of secondary carbohydrates, as long as the 
cell takes up the preferred carbohydrates. Each of these functions revolves around PTS 
facilitating the transfer of phosphoryl groups from PEP, the phosphoryl donor, to the incoming 
carbohydrate molecules. 
 The PTS consists of three components: EI, HPr, and EII (72) (Fig. 3). The EI and HPr 
components are generic to the PTS, serving only to transfer phosphoryl groups from PEP to EI 
to HPr to EII. The EII component is specific for each preferred carbohydrate and serves as the 
transporter and kinase for that carbohydrate. There are at least 22 known or putative EII 
systems in E. coli, each capable of transporting a different substrate or set of substrates (73). In 
the case of glucose, EII is composed of EIIA(Glc), which is phosphorylated by HPr, and EIICB(Glc), 
which is phosphorylated by EIIA(Glc). As glucose enters through the phosphorylated EIICB(Glc) 
subunit, EIICB(Glc) transfers its phosphoryl group to the glucose molecule, initiating glycolysis 
(72). During glycolysis, two molecules of PEP are formed; the PEP is converted to pyruvate by 
transferring the phosphoryl group to either ADP, forming ATP, or by donating its phosphoryl 
group to EI, which will pass that phosphoryl group down the PTS and on to the next incoming 
glucose molecule. 
 In the absence of glucose, EIICB(Glc) and EIIA(Glc) remain phosphorylated, since there are 
no glucose molecules to accept the phosphoryl groups. The phosphorylated EIIA(Glc) activates 
adenylate cyclase, the enzyme responsible for cAMP synthesis (74) (Fig. 4). Adenylate cyclase  
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Figure 3. The phosphotransferase system. The PTS is phosphorylated by PEP, which is generated by 
glycolysis. PEP donates it phosphoryl group to EI, which passes the phosphoryl group to HPr, which 
passes the phosphoryl group to EIIA, which passes the phosphoryl group to EIIB. As a PTS carbohydrate 
is transported across the membrane by EIIC, EIIB transfers the phosphoryl group to the carbohydrate, 
initiating glycolysis. Glycolysis generates two molecules of PEP, which can provide the phosphoryl 
group for the next incoming carbohydrate molecule. This figure is taken from (71). 
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Figure 4. Catabolite repression/inducer exclusion. When glucose enters the cell via the PTS, members 
of the PTS pass their phosphoryl groups to the incoming glucose molecules, leaving the PTS 
components primarily unphosphorylated. Unphosphorylated EIIA(Glc) inhibits the transporters of 
secondary carbon sources such as lactose (LacY). This “inducer exclusion” prevents lactose from 
entering the cell and inducing transcription of the lac operon. At the same time, unphosphorylated 
EIICB(Glc) sequesters Mlc, a transcriptional inhibitor of the PTS, promoting PTS expression. Once the 
glucose is consumed, the PTS no longer has a substrate to transfer phosphoryl groups to, so it remains 
phosphorylated. Phosphorylated EIIA(Glc) (along with an unknown adenylate cyclase activation factor 
[ACAF]) activates adenylate cyclase, which makes cAMP. cAMP activates CRP, promoting transcription 
of proteins involved in the catabolism of secondary carbohydrates. Figure adapted from (72). 
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activation also requires an unknown adenylate cyclase activation factor (ACAF). The increased 
cAMP levels increase CRP activity, leading to increased expression of genes required for the 
import and catabolism of secondary carbohydrates. In the presence of glucose, EIIA(Glc) and 
EIICB(Glc) readily pass on their phosphoryl groups to the incoming glucose molecules, therefore 
spending much of their time unphosphorylated. The unphosphorylated EIIA(Glc) cannot activate 
adenylate cyclase, causing a reduction in cAMP levels and CRP activity (72). 
 The unphosphorylated form of EIIA(Glc) also interacts with and inhibits the activity of 
certain carbohydrate permeases, including permeases for lactose (75), melibiose (76), and 
maltose (77). This inhibition suppresses secondary carbohydrate catabolism by a mechanism 
referred to as “inducer exclusion” (78). Many carbohydrates act as transcriptional inducers of 
genes involved in their own uptake and catabolism, either by activating a transcriptional 
activator or inhibiting a transcriptional repressor. By inhibiting the activity of the carbohydrate 
permeases, unphosphorylated EIIA(Glc) prevents these carbohydrates from inducing gene 
transcription, and prevents the cell from using these carbohydrates as carbon source until the 
glucose is depleted and EIIA(Glc) is predominately phosphorylated.  
 Finally, the unphosphorylated form of EIICB(Glc) also participates in catabolite repression 
by promoting expression of the PTS (79). Mlc is a transcriptional inhibitor that targets the genes 
encoding EI, HPr, EIIA(Glc), EIICB(Glc), and a few EII subunits specific for other carbohydrates (80). 
Unphosphorylated EIICB(Glc) binds to and sequesters Mlc, relieving repression of PTS (81). 
 In the absence of preferred carbohydrates, the phosphorylation state of the PTS is in 
equilibrium with the PEP:pyruvate ratio (82). A high PEP:pyruvate ratio favors the 
phosphorylation of the PTS; a low PEP:pyruvate ratio favors its dephosphorylation. Carbon 
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sources that decrease the PEP:pyruvate ratio, such as glucose 6-phosphate, can cause the 
dephosphorylation of EIIA(Glc) and EIICB(Glc) even though the carbon sources are not transported 
or phosphorylated by the PTS. As a result, certain non-PTS carbohydrates can still cause 
catabolite repression and inducer exclusion by manipulating the phosphorylation state of the 
PTS. 
 I will summarize this section in the context of glucose-lactose diauxie. As long as glucose 
is available, the PTS quickly transfers phosphoryl groups from PEP to glucose, leaving the PTS 
primarily unphosphorylated. Unphosphorylated EIICB(Glc) sequesters the transcriptional 
repressor Mlc, increasing expression of the PTS. Unphosphorylated EIIA(Glc) inhibits the uptake 
of lactose by direct interaction with the lactose permease LacY. In the absence of lactose, 
allolactose is not generated, so expression of the lac genes remains inhibited by LacI. 
Additionally, unphosphorylated EIIA(Glc) cannot activate AC, so cAMP production and thus CRP 
activity decreases. This further reduces expression of the lac genes, along with genes involved 
in the catabolism of other secondary carbohydrates. Once the glucose is consumed, phosphoryl 
transfer ceases and the PTS remains phosphorylated. Mlc is released and inhibits expression of 
the PTS genes. Lactose enters the cell though LacY and is converted to allolactose, relieving LacI 
repression of the lac operon. Phosphorylated EIIA(Glc) stimulates cAMP production, and cAMP 
binds to and activates CRP, which drives expression of the lac genes. 
 
Overflow Metabolism 
Under ideal conditions, bacteria that can tolerate aerobic conditions undergo aerobic 
respiration to metabolize carbon sources into carbon dioxide, ATP, and other cellular 
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components. However, if the flux of carbon through glycolysis is greater than the flux of carbon 
through the TCA cycle, some of the pyruvate and acCoA generated from glycolysis is diverted 
away from the TCA cycle and into aerobic fermentation in a process called overflow 
metabolism. By doing so, the cell can avoid many problems that come with a less-than-optimal 
TCA cycle flux at the expense of a significant amount of energy and biomass. In this section, I 
will discuss potential causes for a reduction in TCA cycle flux, leading to an imbalance between 
glycolysis and the TCA cycle. Additionally, I will discuss some of the potential problems that can 
arise due to this imbalance, along with some of the strategies E. coli uses to deal with these 
problems. 
In general, there are two non-mutually exclusive causes for a reduction in TCA cycle flux: 
1) reduced expression of TCA cycle proteins, and 2) reduced availability of factors that drive the 
TCA cycle forward. For example, low molecular oxygen levels prevent the expression of several 
TCA cycle enzymes, most notably 2-ketoglutarate dehydrogenase (237). Additionally, low 
molecular oxygen levels prevent NAD+ re-oxidation via aerobic respiration. The TCA cycle 
requires 50% more NAD+ than glycolysis when glucose is the carbon source (Fig. 5A), so NAD+ 
limitation will cause a net decrease in TCA cycle flux relative to glycolytic flux. Low nitrogen 
levels prevent the synthesis of glutamate and glutamine from 2-ketoglutarate (95). Removal of 
some 2-ketoglutarate from the TCA cycle helps to drive the cycle forward, so in the absence of 
glutamate/glutamine synthesis the TCA cycle flux is decreased. It was recently shown that low 
magnesium levels also drive aerobic fermentation, as observed by decreased biomass and 
increased global acetylation (212). This could be due to a decrease in TCA cycle flux, though this 
hypothesis has not been tested. 
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Figure 5. Glycolysis and the TCA cycle. (A) Glucose enters glycolysis at the top of the diagram. After 
phosphorylation and isomerization events, fructose-1,6-bisphosphate is cleaved into glyceraldehyde-3-
phosphate (GAP) and dihydroxyacetone phosphate, which is isomerized to GAP. The two GAP 
molecules are oxidized into two molecules of acCoA, generating a net gain of two ATP and reducing 
four NAD+ per glucose molecule. AcCoA enters the TCA cycle through covalent linkage to oxaloacetate 
to form citrate. Over several steps, citrate is further oxidized, and the two carbons gained from acCoA 
are released as CO2, restoring the original oxaloacetate. Two additional ATP are generated and six 
additional NAD+ are reduced per glucose molecule. In the presence of oxygen, the reduced NAD+ can 
be re-oxidized in the electron transport chain to generate additional ATP. This figure was taken and 
modified from (90) and (237). (B) In the absence of oxygen, or in the presence of non-limiting 
catabolite-repressing carbon sources such as glucose, expression of certain enzymes in the TCA cycle is 
significantly reduced. The most significantly reduced enzyme is 2-ketoglutarate dehydrogenase (KGDH), 
whose activity is essentially absent. The absence of KGDH breaks the TCA cycle into two branches, a 
reductive branch (left) and an oxidative branch (right). Neither branch generates ATP and is used only 
to generate biosynthetic precursors. 
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Growth on non-limiting concentrations of glucose also reduces carbon flux through the 
TCA cycle. Expression of the TCA cycle enzymes is reduced in the presence of glucose (84). Most 
significantly reduced are the 2-ketoglutarate dehydrogenase (KGDH), succinyl-CoA synthetase 
(SCS), and succinate dehydrogenase (SDH) enzymes encoded in the sdh-suc operon, with KGDH 
activity being essentially non-existent (83). At least some of this downregulation can be 
attributed to catabolite repression; CRP positively regulates expression of the sdh-suc operon 
(85). Similar downregulation of the sdh-suc operon occurs in the absence of oxygen, though 
different regulators are responsible (86). Reduction in KGDH, SCS, and SDH levels result in a 
disconnection of the TCA cycle into an oxidative branch and a reductive branch (Fig. 5B). Unlike 
the cyclical version, this branched version of the TCA cycle does not generate ATP and only 
operates biosynthetically (83) at a much-reduced rate (87). 
The absence of a fully functioning TCA cycle can have several negative consequences for 
the cell. First, carbon sources like glucose are rapidly converted to acCoA (88). The amount of 
CoA in the cell is relatively constant (89), so it does not take long before all the CoA is 
sequestered in the form of acCoA. CoA is also required for other biological processes such as 
fatty acid synthesis, so the acCoA must continually be processed to release free CoA. Another 
problem for the cell is that in the absence of the TCA cycle, the NADH generated by glycolysis 
cannot be re-oxidized to NAD+ through oxidative phosphorylation (90). Glyceraldehyde-3-
phosphate dehydrogenase requires NAD+ to function, so NADH must be re-oxidized by some 
other means to allow continued glycolytic flux. Finally, the lack of oxidative phosphorylation 
severely reduces the amount of ATP obtained from carbon sources. 
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To compensate for these issues, the cells undergo fermentation: anaerobic 
fermentation when oxygen is limiting, aerobic fermentation when something other than oxygen 
is limiting. Aerobic fermentation is also referred to as “overflow metabolism”, a seemingly 
wasteful strategy in which the pyruvate and acCoA that accumulates due to reduced TCA cycle 
flux “overflows” into fermentation instead of generating energy through respiration, despite 
the presence of oxygen (243). However, fermentation allows the cell to consume the 
accumulated pyruvate and acCoA, either generating ATP or re-oxidizing NADH to NAD+ in the 
process. Which path the cell takes depends on the current redox and energy status of the cell 
(90). Converting pyruvate into lactate or acCoA into ethanol re-oxidizes NADH into NAD+, which 
is required for glycolysis, but produces no energy. Converting acCoA into acetate generates two 
ATP per glucose molecule, doubling the amount of ATP generated from acCoA synthesis, but 
does not recycle NAD+. Therefore, cells must balance lactate, ethanol, and acetate excretion to 
get the most energy out of the available glucose, while replenishing NAD+ for glycolysis. 
Additionally, ethanol and acetate synthesis releases free CoA back to the cell to use for 
continued glycolytic flux or for cell growth. 
 The ATP-forming pathway that generates acetate in E. coli involves two enzymes, 
phosphotransacetylase (Pta) and acetate kinase (AckA) (Fig. 6). Pta converts acCoA into acP 
using inorganic phosphate, and AckA converts acP into acetate by transferring the phosphoryl 
group to ADP, forming ATP (91). In the presence of high concentrations of acetate (>10 mM), 
this pathway is reversed, consuming ATP to generate acP, and then acCoA (92, 93). At lower 
concentrations of acetate, the acetate is converted to acCoA by a single enzyme, acCoA 
synthetase (Acs), without an acP intermediate. A more detailed description of Acs activity and  
24 
 
 
 
  
Glycolysis 
acCoA 
acP 
Acetate 
[Acetyl‐AMP] 
Acs 
Acs 
Pta 
AckA 
CoASH 
Pi 
ADP 
ATP ATP 
PPi 
CoASH 
AMP 
Figure 6. The acetate activation pathway. Acetyl CoA produced from glycolysis is converted to acetyl 
phosphate by Pta. Acetyl phosphate is then converted to acetate, producing one ATP, and then 
excreted from the cell. This half of the pathway is reversible in high concentrations of acetate. In low 
concentrations of acetate, acetate is converted to acetyl CoA by Acs via an acetyl‐AMP intermediate. 
This process requires the hydrolysis of ATP to AMP and is irreversible. 
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its regulation will be presented in the next section (see Chapter One – Protein Acetylation – Nε-
Lysine Acetylation). 
 Besides simply acting as an intermediate between acCoA and acetate, acP can post-
translationally modify proteins by direct transfer of either its acetyl group or phosphoryl group. 
Protein acetylation is a recently discovered function of acP and will be discussed in detail in the 
next section (see Chapter One – Protein Acetylation – Nε-Lysine Acetylation). Protein 
phosphorylation by acP has been best studied in the context of two-component signal 
transduction (TCST) systems. In TCST systems, a histidine kinase senses a signal and 
autophosphorylates using ATP. The phosphoryl group is then passed to a response regulator, 
either directly or through a series of intermediate phosphorylation events. Phosphorylation of 
the response regulator alters its behavior, culminating in a cellular response to the original 
signal. AcP can directly phosphorylate many response regulators, providing an alternative 
activation mechanism independent of their associated histidine kinases (90, 94). The ability of 
acP to post-translationally modify proteins suggests acP levels are a signal sensed by the cell, 
perhaps to monitor a reduction carbon flux through the TCA cycle relative to carbon flux 
through glycolysis (95).  
  
Protein Acetylation 
 Post-translational modifications permit cells to respond to changing environmental 
conditions by modifying existing proteins, altering their activity, localization, interactions with 
other proteins or nucleic acids, and/or stability (96). Many modifications are reversible, 
enabling a temporal adjustment to a protein’s function. A single protein can carry multiple 
26 
 
 
 
different modifications, and cross-talk can occur between modifications (97). Each combination 
of modifications on a particular protein could be considered a unique isoform, greatly 
expanding the proteome beyond the constraints of the genome (98, 99). 
 One of the most common post-translational modifications in E. coli, and a subject of this 
dissertation, is protein acetylation. In this section, I will discuss protein acetylation in three 
parts: Nα-acetylation, Nε-lysine acetylation, and O-acetylation. 
Nα-Acetylation 
 Nα-acetylation is the irreversible transfer of the acetyl group of acCoA to the α-amino 
group in the N-terminal amino acid of a protein. This modification is extremely common in 
eukaryotes, occurring on 60-80% of proteins (100). In bacteria, Nα-acetylation is much more 
rare. Only 47 E. coli proteins have been detected as Nα-acetylated, comprising only 1% of its 
genome (101). In Pseudomonas aeruginosa, the number of identified Nα-acetylated proteins is 
117, totaling about 2% of its genome (102). 
 Eukaryotes possess up to six different N-terminal acetyltransferases (NATs), though 
three of these NATs (NatA-C) catalyze as many as 90% of the Nα-acetylation reactions in 
eukaryotes (103). These NATs recognize their targets based on the sequence of the two initial 
amino acids residues in the target protein, and whether the initial methionine has been cleaved 
by an aminopeptidase. NATs associate with ribosomes, allowing the acetylation reaction to 
occur co-translationally in most cases (104). Nα-acetylation regulates protein activity in many 
ways, including protein-protein interactions (105), localization (106), sorting (107), folding 
(108), and proteasomal degradation (109), and has been implicated in human disease (110, 
111) and cancer (112, 113). 
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 E. coli encodes three NATs, RimJ, RimL, and RimI. Despite having related functions, the 
bacterial NATs are not related to the eukaryotic NATs, suggesting that each group evolved 
independently (114). Unlike in eukaryotes, Nα-acetylation is performed post-translationally in 
bacteria (103). RimJ, RimL, and RimI Nα-acetylate ribosomal proteins S5 (115), L12 (116), and 
S18 (117), respectively. No other endogenous targets of the Rim proteins have been identified, 
and it is not known which proteins acetylate the other Nα-acetylated proteins in E. coli, 
suggesting the existence of additional NATs. Loss of either RimI or RimL results in no known 
phenotype (116, 117). RimJ appears to play a role in ribosome assembly (118) and transcription 
of the pap operon (119), though these roles may be independent of the acetyltransferase 
activity of RimJ. As a result, the significance of Nα-acetylation in E. coli has yet to be 
determined. 
Nε-Lysine Acetylation 
In contrast with Nα-acetylation, Nε-lysine acetylation is the transfer of an acetyl group 
specifically onto the ε-amino group of a lysine residue (Fig. 7). Using acCoA as the acetyl group 
donor, this reaction is catalyzed by lysine acetyltransferases (KATs), and in some cases can be 
reversed by lysine deacetylases (KDACs). AcP can also function as a non-enzymatic acetyl group 
donor in some bacteria (120, 121). Nε-lysine acetylation results in the neutralization of the 
lysine’s positive charge, which can affect the protein’s activity, localization, interactions with 
other proteins or nucleic acids, and/or stability (96). 
Nε-lysine acetylation was first identified as a post-translational modification of histones 
in eukaryotes (122). Since then, it has been realized that Nε-lysine acetylation is one of many 
histone modifications that make up a “histone code,” in which combinations of post- 
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Figure 7. Nε-lysine acetylation. The acetyl group from acCoA can be transferred to the ε-amino group 
of a lysine sidechain through the action of a lysine acetyltransferase (KAT). Some of these acetylations 
can be reversed by the action of a lysine deacetylase (KDAC). In some bacteria, acP can also be an 
acetyl group donor. Acetylation by acP does not appear to require a KAT. Much like KAT-dependent 
acetylation, some of the acP-dependent acetylations can be reversed by KDACs. Figure adapted from 
(238). 
acP 
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translational modifications on histone tails have specific effects on local transcription (123). Nε-
lysine acetylation affects histones by loosening their interaction with DNA (124) and recruiting 
other histone-modifying enzymes (125) or DNA binding proteins (126). 
Histones are not the only eukaryotic proteins that undergo Nε-lysine acetylation. 
Thousands of human proteins have been detected as acetylated in the nuclear, cytoplasmic, 
and mitochondrial compartments (127, 128). For example, acetylation of the transcription 
factor p53 promotes p53 activity by recruiting additional coactivators and histone 
acetyltransferases, enhancing the activation of p53-dependent promoters (129). Stable α-
tubulin polymers are highly acetylated, while overexpression of the KDAC HDAC-6 induces 
depolymerization (130). Almost every enzyme in glycolysis, gluconeogenesis, the TCA cycle, the 
urea cycle, fatty acid metabolism, and glycogen metabolism is acetylated at some level, and the 
acetylation pattern changes based on nutrient availability, though the function of most of these 
acetylations remains unknown (128). However, since acCoA is the acetyl group donor in 
eukaryotes and acCoA is the keystone intermediate of central metabolism, acetylation of 
metabolic enzymes may allow the cell to monitor its metabolic status. 
Nε-lysine acetylation is also a highly abundant modification in bacteria, occurring on 
thousands of lysines spanning hundreds of proteins of diverse function. It has been identified in 
E. coli (120, 121, 131–137), S. enterica (138), B. subtilis (139, 140), B. amyloliquefaciens (141), G. 
kaustophilus (142), E. amylovora (143), M. tuberculosis (144), S. eriocheiris (145), T. 
thermophilus (146), and C. glutamicum (147). Despite the vast number and diversity of 
acetylated proteins, very few KATs have been identified. E. coli encodes one known KAT, YfiQ 
(148) (also called PatZ or Pka in E. coli and Pat in S. enterica). Some, but not most, of the YfiQ-
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mediated acetylations are reversed by the NAD+-dependent KDAC CobB (149). A recently 
discovered NAD+-independent KDAC YcgC deacetylates a set of proteins that is at least partially 
distinct from CobB (150), suggesting protein deacetylation is highly regulated. 
In addition to KAT-mediated Nε-lysine acetylation, non-enzymatic Nε-lysine acetylation 
can occur in bacteria that synthesize acP, a metabolic intermediate that can function as either a 
phosphoryl or acetyl group donor (90, 120, 121, 139). In E. coli and B. subtilis, acP-dependent 
Nε-lysine acetylation appears to be the dominant acetylation mechanism. While there is no 
clear consensus sequence to identify lysines susceptible to acP-mediated acetylation, 
susceptible lysines appear to have two characteristics in common: nearby positively charged or 
hydrogen bond-donating residues to interact with the negatively charged phosphoryl group, 
and nearby negatively charged residues to deprotonate and enhance the reactivity of the target 
lysine (121). 
Much like in eukaryotes, metabolic enzymes are highly acetylated in bacteria (131, 138, 
151). This has led to the hypothesis that metabolism and Nε-lysine acetylation are linked. 
Glucose greatly enhances the number of Nε-lysine acetylations in both S. enterica and E. coli 
(138, 152). In S. enterica, it is suggested that Nε-lysine acetylation by Pat and deacetylation by 
CobB promote glycolysis and gluconeogenesis respectively (138). In E. coli, CRP, a major 
regulator of secondary metabolism, is also required for the majority of these acetylations (153). 
The mechanism by which CRP promotes Nε-lysine acetylation is not established; however, 
cAMP, which is required for CRP activity, enhances expression of the KAT YfiQ (151). YfiQ-
dependent Nε-lysine acetylation only makes up a fraction of total Nε-lysine acetylation in E. coli 
(120, 121), so other mechanisms by which CRP regulates Nε-lysine acetylation must exist. 
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Whether CRP regulates YfiQ expression, and whether CRP contributes to glucose-dependent 
Nε-lysine acetylation in other ways, has yet to be determined. 
 One of the first and best-studied example of Nε-lysine acetylation is the regulation of 
acetyl-CoA synthetase (Acs) activity (154). Acs synthesizes acCoA from acetate through the 
formation of an acetyl-AMP intermediate. In S. enterica, Pat acetylates Acs on K609, which 
inhibits the formation of the acetyl-AMP intermediate, but has no effect on the conversion of 
acetyl-AMP to acCoA (154, 155). Acetylation of K609 by Pat requires Acs L641, which is 
predicted to be involved in the Pat-Acs interaction (156). The NAD+-dependent deacetylase 
activity of CobB reverses K609 acetylation, restoring Acs activity (154). Thus, when the cell has 
plenty of energy, high concentrations of acCoA provide the acetyl group donor to inhibit Acs 
activity and acetate uptake through Nε-lysine acetylation. On the other hand, in the absence of 
glycolytic carbon sources, oxidized NAD+ accumulates. This provides a substrate for CobB to 
deacetylate Acs and activate acetate metabolism. Regulation of Acs activity by Nε-lysine 
acetylation is similar in E. coli (151) and B. subtilis (157), though activation of Acs in B. subtilis 
requires two deacetylases. 
 RNase R is an exoribonuclease in E. coli responsible for the degradation of highly 
structured RNAs (158). In exponential phase growth, RNase R is Nε-lysine acetylated by YfiQ on 
K544 (148). Acetylated RNase R is bound by both tmRNA and its accessory protein SmpB, 
members of the trans-translation pathway that rescues stalled ribosomes (159, 160). This 
binding induces RNase R degradation by the Lon protease (161). In stationary phase, RNase R is 
no longer acetylated by YfiQ (162). The absence of K544 acetylation prevents the interaction 
between RNase R and the tmRNA-SmpB complex, saving RNase R from Lon-dependent 
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degradation. Unlike Acs acetylation, RNase R K544 acetylation appears to be irreversible. 
Instead, the growth phase-dependent acetylation pattern of RNase R follows the expression 
pattern of YfiQ; YfiQ steady state levels are high in early exponential phase and gradually 
decrease into stationary phase (162). This is one example of Nε-lysine acetylation regulating the 
stability of a protein. 
 There is evidence that transcriptional regulators may also be regulated by Nε-lysine 
acetylation. The regulator of capsule synthesis B (RcsB) is the response regulator of the Rcs 
phosphorelay system (163). RcsB becomes phosphorylated and binds to DNA, regulating the 
transcription of genes involved with biofilm maturation, motility, and cell division. AcP-
dependent acetylation of RcsB K154 reduces RcsB-dependent rprA promoter activity to baseline 
levels without interfering with RcsB DNA binding (164). YfiQ also acetylates RcsB in vitro on 
K180, located within the RcsB DNA binding domain, which does reduce binding to the flhDC 
promoter (165). However, whether YfiQ acetylates K180 in vivo has been called into question 
(164). 
 Nε-lysine acetylation of CRP has been reported on several occasions (120, 121, 131–137, 
166) , but the role of Nε-lysine acetylation on CRP function has not been investigated. One of 
the first and most consistently-identified acetylated lysines within CRP is K100 (120, 121, 131–
134, 136), which is adjacent to K101 and AR2, a region critical for CRP activity at Class II 
promoters (25). Several other lysines have been identified as acetylated, some of which are also 
very near or within regions critical for CRP function (Fig. 2). For example, K188 (120, 121, 133, 
134) is very close to the DNA-binding HTH motif. K166 (120, 121, 132, 133, 136) and K201 (120, 
121, 133, 134, 166) are near AR1. K101 (120, 133) and K52 (120, 133, 135) are components of 
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AR2 and AR3, respectively. Acetylation of any of these lysines could have a significant impact on 
CRP function. Considering the scope of the CRP regulon (12), CRP acetylation could also have a 
significant impact on cell physiology. 
 It is clear that Nε-lysine acetylation is a widespread phenomenon, and it has been 
compared to protein phosphorylation in terms of abundance, mechanism, and regulatory 
capacity (167, 168). Unlike protein phosphorylation, very little is known about the effect of 
individual acetylations, due to the infancy of the field. With such a limited understanding, the 
effect of Nε-lysine acetylation on a protein’s function currently must be studied on a case-by-
case basis. 
O-Acetylation 
 In addition to the better-known protein acetylations discussed above, some species of 
pathogenic bacteria are capable of acetylating the hydroxyl sidechains of internal serine and 
threonine histidine residues within eukaryotic proteins. One proposed function of 
serine/threonine acetylation is to prevent the phosphorylation of these regulatory serines and 
threonines in the target proteins. For example, Yersinia species encode a Ser/Thr 
acetyltransferase YopJ, which is secreted into mammalian host cells to block innate immune 
signaling (169). Once inside the host cell, YopJ acetylates lysine, serine, and threonine residues 
within MAPKKs and IKKβ. The serine and threonine acetylations prevent phosphorylation of 
these key residues, inhibiting the activation of the MAPKKs and IKKβ. YopJ also acetylates 
serine, threonine, and lysine residues within TGFβ-activated kinase (TAK1) in both Drosophila 
and mammals, resulting in TAK1 inactivation (170).  
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Another YopJ family member, HopZ3 from Pseudomonas syringae, also prevents 
immune signaling in Arabidopsis through protein acetylation (171). HopZ3 acetylates several 
immunity-related proteins in Arabidopsis on lysine, serine, and threonine residues, along with 
the acetylation of a single histidine residue within AvrB3. While serine, threonine, and even 
tyrosine acetylation has been observed in histones (172), YopJ family members are the only 
known mediators of stable histidine acetylation. The continued discovery of novel protein 
acetylation modifications and their crosstalk with other modifications implies that protein 
acetylation plays a much bigger regulatory role than previously thought. 
 
Summary 
Bacteria must regulate their proteome to ensure the right proteins are not only 
expressed but also active at the right time. Some of this regulation takes the form of PTMs. 
These PTMs alter the function of proteins, either as a binary “on-off” switch or as a subtler 
rheostat. Another part of this regulation is in the form of transcriptional regulation: the control 
of the timing of gene expression, which ultimately leads to protein expression. In this 
dissertation, I propose an intimate relationship between these two modes of regulation. 
In Chapter Three, I investigate the involvement of CRP in Nε-lysine acetylation. CRP is 
required for the majority of glucose-induced acetylation. cAMP, the allosteric activator of CRP, 
promotes the expression of yfiQ, the only reported KAT in E. coli. Does CRP promote yfiQ 
expression as well? Regardless, the relatively few YfiQ-mediated acetylations cannot account 
for all CRP-dependent acetylation. Could CRP also promote acP-dependent acetylation? 
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In Chapter Four, I investigate the involvement of Nε-lysine acetylation in CRP activity. 
Several lysines in CRP can be acetylated, including K100. The proximity of K100 to AR2 suggests 
K100 acetylation could influence Class II transcription, while having little impact on Class I 
transcription. The existence of two different classes of CRP-dependent promoters suggests the 
possibility that each class could be regulated separately, though no mechanism of differential 
regulation has been proposed. Could K100 acetylation be a mechanism to separate CRP-
dependent Class II activity from Class I activity?  
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CHAPTER TWO 
MATERIALS AND METHODS 
 
Bacterial Strains, Plasmids, and Primers 
All bacterial strains, plasmids, and primers used in this dissertation are listed in Table 1. 
Mutant strains were constructed by generalized transduction using P1kc (for details, see 
“Generalized P1 Transduction”). 
 
Culture Conditions 
 For strain construction, cells were grown in Luria Broth (LB) containing 1% 
(w/v) tryptone, 0.5% (w/v) yeast extract, and 0.5% (w/v) sodium chloride; 
LB plates also contained 1.5% agar. Unless otherwise noted, for all assays that required 
culturing bacteria in liquid media, cells were grown in tryptone broth buffered to pH 7 (TB7), 
containing 1% (w/v) tryptone, 61.5 mM potassium phosphate dibasic, and 38.5 mM potassium 
phosphate monobasic. Cultures were grown with aeration by shaking at 225 rpm at 37°C unless 
otherwise noted. Cell growth was monitored spectrophotometrically (DU640; Beckman 
Instruments, Fullerton, CA) by determining the optical density at 600 nm (OD600). 
 Antibiotics were prepared as a stock solution 1000 times the working concentration. 
Working concentrations were as follows: ampicillin, 100 μg/mL; kanamycin, 40 μg/mL; 
tetracycline, 15 μg/mL; and chloramphenicol, 25 μg/mL. Stock solutions of ampicillin and 
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kanamycin were dissolved in water and filter sterilized. Stock solutions of tetracycline and 
chloramphenicol were dissolved in 50% and 100% ethanol, respectively, and filter sterilized. All 
antibiotic stocks were stored at -20°C. 
 
Generalized P1 Transduction 
1 mL of an overnight culture grown in 5 mL LB (plus antibiotic if appropriate) was 
pelleted and resuspended in 1 mL TBT (TB with 0.2% [w/v] glucose, 10 mM calcium chloride, 10 
mM magnesium sulfate, 0.04 mM ferric chloride). 100 μL phage lysate was added to the 
resuspended cells and incubated statically at 37°C for 30 minutes. 200 μL of 1 M sodium citrate, 
pH 5.5 was added to the infected cells to prevent further infection. The infected cells were 
pelleted and resuspended in 500 μL LB, then 200 μL of 1 M sodium citrate, pH 5.5 was added to 
the resuspension. The cells were incubated statically at 37°C for 70 minutes. The cells were 
pelleted and resuspended in 100 μL sodium citrate, pH 5.5. The entire 100 μL of transduced 
cells was plated onto LB plates containing the appropriate antibiotics and incubated at room 
temperature for 48 hours, or until colonies appeared. 
 
Plasmid Construction 
 Plasmid p770-yfiQ’ is a derivative of p770 (a generous gift from Rick Gourse at the 
University of Wisconsin-Madison). It is an ampicillin-resistant ColE1-based plasmid that has the 
tandem rrnB operon terminators T1 and T2 located downstream of the insertion sites for the 
promoter. The yfiQ promoter region was amplified from strain AJW678 with primer pair yfiQ’ 
EcoRI F and yfiQ’ HinDIII R to insert the EcoRI site upstream of the promoter region and the 
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HinDIII site downstream. The resulting amplicon was ligated into pJET1.2, using the CloneJET 
PCR Cloning Kit (Fermentas) following kit instructions. The ligated yfiQ’ insert was sequenced, 
digested out of pJET1.2 with EcoRI and HinDIII, and gel-extracted. The gel-extracted fragment 
was cloned into previously digested p770 via overnight ligation at room temperature. Ligated 
plasmids were transformed into E. coli DH5α cells. Plasmids were recovered from 
transformants and restriction digested to screen for the presence of the yfiQ promoter. The 
presence of the promoter was confirmed via sequencing analysis. The plasmid containing the 
correct insert was purified, stored at -20°C and named p770-yfiQ’. 
 
Site-Directed Mutagenesis 
Site-directed mutagenesis of crp in pDCRP was performed using either the QuikChange II 
Site-Directed Mutagenesis Kit or the QuikChange Lightning Multi Site-Directed Mutagenesis Kit 
(Agilent Technologies) per the manufacturer’s instructions. Primers used for site-directed 
mutagenesis can be found in Table 1. Mutations were confirmed by sequence analysis of the 
purified mutagenized plasmid. 
 
Transformation 
Three distinct transformation methods were used: transformation buffers (TBF), 
transformation storage solution (TSS), and electroporation. 
TBF 
 Overnight cultures grown in LB (plus antibiotic if appropriate) were subcultured into 10 
mL LB (plus antibiotic if appropriate) and shaken at 225-250 rpm at 37°C until the OD600 reached 
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0.4-0.6. The culture was cooled on ice for 5 minutes and then pelleted. The supernatant was 
removed and the pellet was resuspended with 4 mL cold TBF1 (30 mM potassium acetate, 100 
mM potassium chloride, 10 mM calcium chloride, 50 mM manganese chloride, 15% glycerol, pH 
to 5.8 with acetic acid). The cells were pelleted, supernatant removed, then the pellet 
resuspended with 0.4 mL cold TBF2 (10 mM MOPS, 75 mM calcium chloride, 10 mM potassium 
chloride, 15% glycerol, pH to 6.5 with potassium hydroxide). The cells were chilled on ice for 30-
60 minutes before use. 1 μL plasmid DNA was added to 50 μL chemically competent cells and 
chilled on ice for 10 minutes. The cell-DNA mixture was heat shocked in a waterbath for 45 
seconds at 42°C, then chilled on ice for 2 minutes. 1 mL LB was added to the transformed cells, 
and the cells were shaken at 225-250 rpm at 37°C for one hour. 100 μL of the transformed cells 
were plated onto LB plates containing the appropriate antibiotics and incubated at 37°C 
overnight, or until colonies appeared. 
TSS 
 Overnight cultures grown in LB (plus antibiotic if appropriate) were subcultured into 5 
mL LB (plus antibiotic if appropriate) and shaken at 225-250 rpm at 37°C until the OD600 reached 
0.3-0.4. 1 mL of the culture was pelleted and resuspended in 100 μL TSS (LB containing 10% 
[w/v] PEG, 5% (v/v) DMSO, 50 mM magnesium sulfate). 1 μL plasmid DNA was added to the 
cells and chilled on ice for 30 minutes. The cell-DNA mixture was heat shocked in a waterbath 
for 2 minutes at 42°C. 900 μL LB was added to the transformed cells, and the cells were shaken 
at 225-250 rpm at 37°C for one hour. 100 μL of the transformed cells were plated onto LB 
plates containing the appropriate antibiotics and incubated at 37°C overnight, or until colonies 
appeared. 
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Electroporation 
 Overnight cultures grown in LB (plus antibiotic if appropriate) were subcultured into 35 
mL LB (plus antibiotic if appropriate) and shaken at 225-250 rpm at 37°C until the OD600 reached 
0.4-0.6. 30 mL of culture (divided into two 15 mL aliquots) were centrifuged at 6700 rpm for 7 
minutes. The supernatant was removed and each pellet was resuspended in 1 mL cold water. 
An additional 9 mL cold water was added to each cell suspension, bringing the volume to 10 mL 
each. The cell suspensions were centrifuged at 6700 rpm for 7 minutes. The supernatant was 
removed and each pellet was resuspended in 1 mL cold water. Each cell suspension was 
pelleted, the supernatants were removed, and each pellet was resuspended in 100 μL cold 
water for a total of 200 uL electrocompetent cells. 1 μL plasmid DNA was added to 50 μL 
electrocompetent cells, which was then transferred to a chilled electroporation cuvette with a 
0.1 cm gap and electroporated at 1.8 kV. 1 mL LB was added to the transformed cells, and the 
cells were shaken at 225-250 rpm at 37°C for one hour. 100 μL of the transformed cells were 
plated onto LB plates containing the appropriate antibiotics and incubated at 37°C overnight, or 
until colonies appeared. 
 
CRP Expression and Purification 
CRP expression was carried out in BL21(DE3) cells carrying pET15b-crp. Overnight 
cultures grown in LB with ampicillin were subcultured into 500 mL LB with ampicillin and 
shaken at 225-250 rpm at 37°C until the OD600 reached 0.4-0.6. 500 μL of 1 M IPTG was added 
to the culture to induce CRP expression, then the culture was allowed to shake for 3 more 
hours. The cells were divided into two 250 mL aliquots and centrifuged at 5000 rpm for 15 
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minutes to pellet the cells. The supernatant was removed and the pellets were stored at -80°C 
overnight. After thawing, each pellet was resuspended in 5 mL BugBuster (Novagen), 5 μL 
lysozyme, and 5 μL Benzonase. The resuspensions were incubated with shaking at room 
temperature for 30-40 minutes to lyse the cells. 15 mL Resuspension Buffer (50 mM disodium 
phosphate, 1.4 M sodium chloride, 20 mM imidazole, 0.1% [v/v] Tween-20, 5% [v/v] ethanol, 15 
mM β-mercaptoethanol, pH 8.0) was added to each resuspension, then the resuspensions were 
centrifuged at 11500 rpm for 30 min at 4°C. The supernatant was collected and loaded onto a 
500 μL Ni-NTA His-Bind Resin (Novagen) column. The column was washed with NiNTA Wash 
buffer (50 mM disodium phosphate, 0.3 M sodium chloride, 30 mM imidazole, 0.1% [v/v] 
Tween-20, 5% [v/v] ethanol, pH 8.0). CRP was eluted from the column by passing 1 mL volumes 
of NiNTA Wash buffer containing increasing concentrations of imidazole (50 mM, 75 mM, 100 
mM, 150 mM, and 200 mM). The 50 mM, 75 mM, and 100 mM imidazole elutions were pooled 
and dialyzed in 1 L Storage Buffer (10 mM Tris-HCl pH 8.0, 100 mM potassium chloride, 50% 
[v/v] glycerol, 10 mM magnesium chloride, 0.1 mM EDTA, 1 mM DTT) overnight. The purified 
CRP was divided into aliquots and stored at -80°C for future use. This protocol was modified 
from (173). 
 
In Vitro Transcription 
In vitro transcription from the yfiQ promoter was executed by multiple round 
transcriptions. The final volume of the in vitro transcription reaction was 25 μL and contained 
1x in vitro transcription buffer (40 mM Tris-HCl pH 8.0, 10mM MgCl2, 50 mM KCl, 1mM DTT and 
25 ng BSA), 1X NTP mixture (200 μM ATP, CTP and GTP, and 10 μM UTP), 2 μCi alpha [32P]UTP, 
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50 ng p770-yfiQ’ plasmid, purified CRP at concentrations ranging from 2.5-40 μM, 200 μM 
cAMP, and 10 nM of purified RNA polymerase-containing sigma 70 (Eσ70). When multiple 
reactions were performed per experiment, they were started at 30 second intervals by the 
addition of Eσ70 and incubated at 30°C for 15 minutes. After incubation, the reactions were 
stopped (also at 30-second intervals) by the addition of 25 μl of 2x stop solution (7 M Urea, 10 
mM EDTA, 1% SDS, 2X TBE and 0.05% bromophenol blue). Immediately following the addition 
of the stop solution, the reactions were transferred onto ice.  
The transcript fragments were separated using a denaturing acrylamide gel containing 
(6% acrylamide [19:1 acryl.:bis.], 7 M urea and 1x TBE). Polymerization was initiated by the 
addition of 0.01% of freshly made 10% APS solution and 0.001% TEMED and allowed to 
polymerize for 1 hour and 30 minutes undisturbed at room temperature. 
23 μL of the in vitro transcription/stop solution reaction was loaded into the gel wells. 
The samples were allowed to run at approximately 200V for approximately 1.5-2 hours until the 
dye reached a position approximately 3 inches from the bottom of the gel, which keeps the 
unincorporated radioactivity on the gel and makes cleaning up the radioactive waste much 
easier. 1x TBE was used as the running buffer. Prior to phosphor imaging, the gels were dried 
using a gel drier for 2 hours. Images were obtained by exposing a storage phosphor screen to 
the dry gel overnight. The screen was read using a Typhon phosphoimager. The unused in vitro 
transcription reaction was stored at -20°C. 
 
 
 
43 
 
 
 
qRT-PCR 
For quantification of yfiQ and crp mRNA, cells were grown in TB7 supplemented with 22 
mM glucose at 37°C and harvested in late exponential phase (OD600 ~1.5). For quantification of 
flhD mRNA, cells were grown in 1% (w/v) tryptone and 0.5% sodium chloride at 30°C and 
harvested in mid-exponential phase (OD600 ~0.5).  
1 mL culture was added to 2 mL RNAProtect Bacterial Reagent (Qiagen), and vortexed. 
After centrifugation, the cell pellet was frozen at -80°C and stored overnight. RNA was 
extracted using the MasterPure RNA Purification kit (EpiCentre). To extract RNA, the cell pellets 
were resuspended by adding 300 µl Tissue and Cell lysis solution and 2 µl proteinase K. The 
resuspensions were incubated at 65°C for 15 minutes, vortexing every 5 minutes. After cooling 
the resuspensions to room temperature, protein was precipitated by adding 175 μL MPC 
Protein Precipitation Reagent, briefly vortexing, then centrifuging for 20 minutes at 13500 rpm 
and 4°C. The supernatant was transferred to a new tube and the nucleic acid was precipitated 
by adding 500 μL isopropanol. The mixture was centrifuged for 30 minutes at 13500 rpm and 
4°C. After discarding the supernatant, the pellet was resuspended in 195 μL 1x DNase Buffer 
and 5 uL RNase-free DNase I, and incubated for 30 minutes at 37°C. After incubation, 200 μL 2x 
T and C Lysis solution was added, and the mixture was immediately vortexed. 200 μL MPC 
Protein Precipitation reagent was added, and the mixture was immediately vortexed again. The 
mixture was centrifuged for 20 minutes at 13500 rpm and 4°C. The supernatant was 
transferred to a new 1.5 mL Eppendorf tube. The ribonucleic acid was precipitated by adding 
500 μL isopropanol, mixing by inversion, and centrifuging for 30 minutes at 13500 rpm and 4°C. 
The supernatant was discarded, and the pellet was rinsed twice with 200 μL 75% ethanol. After 
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removing any residual ethanol, the pellet was resuspended in 30 uL RNase-free water. 1 μL 
RiboGuard RNase inhibitor (EpiCentre) was added to the RNA. RNA concentration was 
measured using a NanoDrop 2000 spectrophotometer (Thermo). RNA was stored at -80°C until 
cDNA synthesis. 
1 μg RNA was used to synthesize cDNA, using the iScript cDNA Synthesis Kit (BioRad), 
according to the manufacturer’s protocol. Quantitative reverse transcription PCR (qRT-PCR) was 
performed using iTaq Universal SYBR Green Supermix (BioRad), according to manufacturer’s 
protocol, on a CFX96 Real-Time System (BioRad) with a C1000 Thermal Cycler (BioRad) and the 
following conditions: 95°C for 5 min, then 37 cycles of (95°C for 15 sec, 60°C for 20 sec, 72°C for 
30 sec). Quantitation of 16S rRNA was used to normalize the data. The list of primers used can 
be found in Table 1. Each experiment included at least two replicates and was performed at 
least twice. 
 
Western Immunoblot Analysis 
Cultures were grown at 37°C in TB7 supplemented with 22 mM glucose. At the indicated 
timepoints cells were harvested, pelleted, and lysed with Bugbuster protein extraction reagent 
(Novagen 70584) using the manufacturer’s protocol. The whole cell protein lysate was 
normalized to protein concentration by BCA assay (Pierce 23225), and equal amounts of protein 
were boiled in 2x loading buffer [0.1 M Tris pH 6.8, 4% (w/v) SDS, 12% (v/v) β-mercaptoethanol, 
20% (v/v) glycerol, 0.001% (w/v) bromophenol blue] for 5 minutes. The samples were separated 
by SDS-polyacrylamide gel electrophoresis with 4.6 M urea in 1x running buffer [25 mM Tris, 
200 mM glycine, 3.5 mM SDS]. The gel was transferred to a nitrocellulose membrane in 1x 
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transfer buffer [25 mM Tris, 200 mM glycine, 3.5 mM SDS, 20% (v/v) methanol] for 1.5 hr at 
100V at 4°C. The blot was blocked with 5% (w/v) BSA prepared in PBST [PBS containing 0.05% 
(v/v) Tween-20] for 30 min at room temperature. To detect and quantify CRP, monoclonal 
mouse primary antibodies against CRP (BioLegend 664304, 1:2000) and RNAP α subunit 
(BioLegend 663102, 1:2000) were diluted in 5% BSA in PBST at 4°C overnight. To detect and 
quantify acetylation, a polyclonal rabbit primary antibody against acetyllysine (Cell Signaling 
#9441L, 1:2000) was diluted in 5% BSA in PBST at 4°C overnight. The blot was washed three 
times for 5 min each with TBST [TBS containing 0.05% (v/v) Tween-20] and then incubated with 
either HRP-conjugated goat anti-mouse secondary antibody (to detect CRP/RNAP α subunit, 
Millipore AP503P, 1:2500) or HRP-conjugated goat anti-rabbit secondary antibody (to detect 
acetylation, Cell Signaling #7074, 1:5000) in 5% milk in TBST for 2 h at room temperature. The 
blot was washed three times for 5 min each with TBST and exposed using 20X LumiGLO Reagent 
and Peroxide (Cell Signaling 7003) and detected using a FluorChem E imager (ProteinSimple). All 
experiments were performed at least twice. 
To quantify CRP steady state levels, the intensities of the bands corresponding to CRP 
and RNAP α subunit were quantified from the digital image obtained from the FluorChem E 
imager using ImageJ version 1.47 (imagej.nih.gov/ij). For each sample, the raw intensity of the 
band corresponding to CRP was divided by the raw intensity of the band corresponding to RNAP 
α subunit to normalize CRP values across samples for each experiment. 
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Promoter Activity Assays 
Cells were grown at 37°C in TB7 supplemented with 0.4% glucose. To monitor promoter 
activity from CC(-41.5) and CC(-61.5), 50 µl culture aliquots were harvested at regular intervals 
and added to 50 µl of All-in-One β-galactosidase reagent (Pierce Biochemical). β-galactosidase 
activity was determined quantitatively using a microtiter format, as described previously (174). 
As a blank, 50 µl of sterile TB7 was used. Each experiment included three biological replicates. 
All experiments were performed at least twice. 
 
Model Characterization 
To visualize interactions between CRP and RNAP at Class II promoter, we created a 
structural model of CRP-RNAP-promoter complex. The structure of the ternary complex of CRP 
and RNAP at a Class II promoter was modeled in Coot (175) based on the three-dimensional EM 
structure of a complex comprising E. coli CRP, RNAP and a DNA fragment from a Class I CRP-
dependent promoter (176). The crystal structure of CRP crystallized in presence of αCTD and 
DNA suggests how the αCTD could interact with AR1 at a Class II promoter and provides details 
of αCTD binding at a non-inhibitory location (177). Interactions between CRP AR2 and RNAP 
involve residues 162-165 located on the flexible loop of N-terminal domain of RNAP αNTD (25). 
To model these interactions, we used a crystal structure of RNAP in complex with squaramide 
compound (178), where the position of the flexible loop is structurally well defined. 
Interactions between the CRP AR3 region and RNAP were modeled based on data described 
previously (57). The figures of model were created in the CCP4 molecular graphics (CCP4mg) 
program (179). 
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Motility Assays 
Overnight cultures grown in LB supplemented were diluted to OD600 3.0-3.5. For each 
strain, 5 µL of diluted culture was spotted onto semi-solid agar plates (1% [w/v] tryptone, 0.5% 
[w/v] sodium chloride, 0.25% [w/v] agar) and allowed to dry for 5 minutes. Once dry, the plates 
were incubated at 30°C for 10 hours. At the end of 10 hours, a ruler was used to measure the 
diameter of each spot. Each experiment included at least eight replicates and was performed 
twice. 
 
In Vitro Acetylation 
Purified CRP (0.5 g/L) and the indicated concentrations of acP were added to acetylation 
buffer (150 mM Tris pH 7.3, 10 mM magnesium chloride, 150 mM sodium chloride, 10% 
glycerol). The acetylation reaction was incubated for either 15 minutes or 120 minutes at 37°C. 
Immediately following incubation, an equal volume of 2x loading buffer [0.1 M Tris pH 6.8, 4% 
(w/v) SDS, 12% (v/v) β-mercaptoethanol, 20% (v/v) glycerol, 0.001% (w/v) bromophenol blue] 
was added to each reaction, and the reactions were incubated at 95°C for 10 minutes. After 
incubation, the reactions were cooled to room temperature and were separated by SDS-
polyacrylamide gel electrophoresis and subjected to Western immunoblot analysis using a 
polyclonal anti-acetyllysine antibody as described above. 
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Quantitative Mass Spectrometry 
In vitro acetylation of CRP was performed in duplicate as described above by incubating 
63.5 ng µl-1 purified CRP with either 0 mM or 12.8 mM acP in acetylation buffer for 15 minutes. 
After SDS-polyacrylamide gel electrophoresis, the gel was stained by incubation with 
SimplyBlue SafeStain (Invitrogen) and destained using deionized water according to the 
manufacturer’s protocol. The prominent band from each sample was cut out of the gel and 
placed in a 1.5 mL Eppendorf tube with deionized water for storage. Gel fragments were 
further destained and dehydrated with ACN. Subsequently, proteins were reduced with 10mM 
dithiothreitol in 25 mM NH4HCO3 at 56 °C for 1 h and alkylated with 55 mM iodoacetamide in 
25 mM NH4HCO3 at room temperature for 45 min. Samples were incubated overnight with 
trypsin (125 ng, 37 °C). The resulting proteolytic peptides were subjected to aqueous (100 µl 
H2O, sonication, 10 min) and hydrophobic extraction (2x 50 µl of 50% ACN, 5% formic acid). 
Extracts were combined, concentrated and desalted using C18 zip-tips (Millipore, Billerica, MA). 
Finally, samples were analyzed by mass spectrometry after concentration under vacuum to a 
10-15 µl final volume. 
For each CRP protein sample, technical duplicates (MS injection duplicates) were 
acquired to assess technical variability. All samples were analyzed by reverse-phase HPLC-ESI-
MS/MS using an Eksigent UltraPlus nano-LC 2D HPLC system (Dublin, CA) connected to a 
quadrupole time-of-flight TripleTOF 5600 mass spectrometer (AB SCIEX), as previously 
described in detail (121). Briefly, the resulting peptides were chromatographically separated on 
a C18 Acclaim PepMap100 reversed-phase analytical column (75 µm I.D.) at a flow rate of 300 
nL/min with a total runtime of 90 min including mobile phase equilibration. The nanoLC system 
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was directly connected to the TripleTOF 5600 operating in data dependent mode with 1 MS1 
survey scan (250 msec) followed by 30 MS/MS scans (50 msec each) per 1.8 second acquisition 
cycle. Mass spectrometric raw data and annotated MS/MS spectral libraries can be accessed at 
massive.ucsd.edu, (MassIVE ID: MSV000080568; password: winter); and at ProteomeXchange 
under PXD005965. The processed MS data is provided in Table 4 to show comprehensive lists of 
un-modified and acetylated CRP peptides that were identified with all their mass spectrometric 
information.  
 
Protein Identification and Quantification 
 For protein identification, all data were searched using Protein Pilot v. 4.5 beta (180), 
using a false discovery rate (FDR) of 1%. A SwissProt E. coli database (SwissProt fasta version 
2013_07) was searched. The following sample parameters were used: trypsin digestion, 
cysteine alkylation set to iodoacetamide, acetylation emphasis, and species E. coli. Trypsin 
specificity was set at C-terminal lysine and arginine. Processing parameters were set to 
"Biological modification" and a thorough ID search effort was used.   
 MS1 chromatogram based quantification was performed in Skyline 2.5 an open source 
software project (http://proteome.gs.washington.edu/software/skyline) as described in detail 
(181). Detailed MS1 Filtering quantification results for acetylated CRP peptides are provided in 
Table 4. Quantification of potential protein level changes upon acP incubation analyzing 23 
robustly observed, non-acetylated peptides by MS1 Filtering is shown in Table 5.  
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RNAseq 
Cells were grown in TB7 supplemented with 22 mM glucose until OD600 ~1.8. 1 mL 
culture was added to 2 mL RNAProtect Bacterial Reagent (Qiagen 76506), and vortexed. After 
centrifugation, the cell pellets were frozen at -80°C and stored overnight. The cell pellets were 
resuspended by adding 300 µl Tissue and Cell lysis solution (EpiCentre) and 2 µl proteinase K. 
The resuspensions were incubated at 65°C for 15 minutes, vortexing every 5 minutes. After 
cooling the resuspensions to room temperature, RNA was isolated using the RNeasy Kit 
(Qiagen) using the manufacturer’s protocol. After isolation, 1 µl RiboGuard RNase inhibitor 
(Epicentre) was added to the purified RNA. RNA purity was determined using a NanoDrop 2000 
spectrophotometer (Thermo Scientific). The amount of total RNA in each sample was quantified 
using the Qubit 2.0 Flurometer (Life Technologies) and quality was assessed using the RNA6000 
Nano Chip on the Bioanalyzer 2100 (Agilent).   
A hybridization-capture process was carried out to remove ribosomal RNA using the 
Ribo-Zero Magnetic Kit (Epicentre) per manufacturer instructions. The rRNA-depleted samples 
were purified using Agencourt RNAClean XP beads (Beckman Coulter) and quality was assessed 
using the RNA6000 Pico Chip and the Bioanalyzer. Using the ScriptSeq v2 Complete Kit 
(Epicentre), the rRNA depleted RNA was fragmented and reverse transcribed using random 
primers that included a unique 5’ tagging sequence. The resulting tagged RNA was tagged once 
more at its 3’ end by the terminal-tagging reaction yielding single-stranded cDNA. The cDNA 
was then amplified using limited cycle PCR, incorporating sequencing adapters and barcodes to 
create a final double-stranded directional cDNA library ready for sequencing. The samples were 
sequenced on the Illumina MiSeq platform rendering 250 bp paired-end reads. 
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To perform data analysis, adapter sequences were removed from raw reads and low 
quality reads were trimmed using a Python-based tool, Cutadapt (182). The resulting reads 
were then mapped to the reference genome of Escherichia coli str. K-12 substr. MG1655, using 
Bowtie2 v. 2.1.0. The aligned sequencing reads and a list of genomic features were used as 
input for the Python package HTSeq to count the mapped genes and generate a table of raw 
counts. The R package, DESeq2 (183), was used to determine differential expression between 
sample groups using the raw count table by fitting the negative binomial generalized linear 
model for each gene and then using the Wald test for significance testing (244). Count outliers 
were detected using Cook’s distance and were removed from further analysis. The Wald test p-
values from the subset of genes that passed an independent filtering step were then adjusted 
for multiple testing using the Benjamin-Hochberg procedure (245). Genes that are up- or down-
regulated with an adjusted p-value of <0.05 AND a fold difference in gene expression >=1.5-fold 
were identified as significantly modulated genes. The global gene expression data discussed in 
this work have been deposited in NCBI's Gene Expression Omnibus (184) and are accessible 
through GEO Series accession number GSE97406 
(https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE97406). 
 
DNA Microarray 
Global gene expression was assessed in M9 minimal medium with 10 mM glucose or 
30mM acetate as the sole carbon source. Aerobic 50 ml batch cultures were grown in 500 mL 
flasks at 37°C on a rotary shaker at 250 rpm. These cultures were inoculated to an initial optical 
density (OD600) of 0.05 units with exponentially growing pre-cultures. Samples for RNA 
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extraction were taken in middle exponential phase (OD600≈0.5) and in stationary phase 
(OD600≈1.5). RNA was purified using VantageTM Total RNA Purification Kit (Origene, Rockville, 
MD, USA). Purity and concentration of isolated RNA were assessed in a NanoDrop One 
spectrophotometer (Thermo Scientific Incorporated, WI, USA). Quality was evaluated by 
microfluidic capillary electrophoresis on an Agilent 2100 Bioanalyzer (Agilent Technologies, Inc, 
USA). Gene expression profiles were analyzed using commercially available oligonucleotide 
microarrays GeneChip E. coli Genome 2.0 Arrays (P/N 900550, Affymetrix, Incorporated, Santa 
Clara, CA, USA). For each microarray, 5 µg of total RNA were used per the manufacturer’s 
instructions (P/N 702232 Rev.3, Affymetrix). 
Data analysis was performed using Partek Genomics Suite 6.6 and Partek Pathway 
(Partek Incorporated, St. Louis, MO, USA), with statistical methods and thresholds described by 
the manufacturer. Data were further analyzed using Affymetrix Transcriptome Analysis Console 
3.0 (TAC). Unless otherwise indicated, genes that are up- or downregulated with a p value <0.05 
were identified as significantly modulated genes. The global gene expression data discussed in 
this work have been deposited in NCBI's Gene Expression Omnibus (184) and are accessible 
through GEO Series accession number GSE96955 
(https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE96955). 
 
CRP Stability Assay 
Cultures were grown in TB7 supplemented with 22 mM glucose at 37°C until OD600 ~0.5. 
Chloramphenicol was added to each culture at a concentration of 200 µg/mL to inhibit protein 
synthesis. At regular intervals, 2 mL samples were collected and centrifuged at 3000 rpm for 12 
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minutes. After removing the supernatant, the cell pellets were stored at -80°C. Western 
immunoblot analysis was performed on the cell pellets as described above using anti-CRP and 
anti-RNAPα antibodies.
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Table 1. Strains, plasmids, and primers.  
Strain Description Reference/Source 
AJW678 thi-1 thr-1(Am) leuB6 metF159(Am) rpsL136 lacX74 (187) 
CB369 MG1655 Δcrp::kan 
Christoph Bausch (University of 
Oklahoma) 
AJW2179 AJW678 λ42(acs205'-lacZ) (239) 
AJW2198 AJW678 λ42(acs205'-lacZ) ∆crp::kan (241) 
AJW4344 AJW678 λ42(acs205'-lacZ) ∆yfiQ::kan P1: AJW2568 x AJW2179 
AJW5105 AJW678 λ42(acs205'-lacZ) ∆ackA-pta::cm P1: AJW2571 x AJW2179 
AJW5174 AJW678 λ42(acs205'-lacZ) ∆ackA::frt 
P1: JW2293 (242) x AJW5173, then 
removed antibiotic cassette 
AJW5179 AJW678 λ42(acs205'-lacZ) ∆ackA::frt ∆crp::kan P1: AJW2033 x AJW5174 
AJW5246 AJW678 Δcrp::kan P1: CB369 x AJW678 
AJW5445 AJW678 Δcrp::frt 
removed antibiotic cassette from 
AJW5246 
AJW5587 AJW678 Δcrp::frt ΔdnaJ::kan P1: JW0014 (242) x AJW5445 
AJW5619 AJW678 Δcrp::frt ΔdnaJ::frt 
removed antibiotic cassette from 
AJW5587 
AJW5621 AJW678 Δcrp::frt ΔdnaJ::frt ΔclpX::kan P1: JW0428 (242) x AJW5619 
AJW5622 AJW678 Δcrp::frt ΔdnaJ::frt ΔclpP::kan P1: JW0427 (242) x AJW5619 
AJW5624 AJW678 Δcrp::frt ΔdnaJ::frt ΔclpY::kan P1: JW3902 (242) x AJW5619 
AJW5625 AJW678 Δcrp::frt ΔdnaJ::frt Δlon::kan P1: JW0429 (242) x AJW5619 
AJW5626 AJW678 Δcrp::frt ΔdnaJ::frt ΔpepE::kan P1: JW3981 (242) x AJW5619 
AJW5628 AJW678 Δcrp::frt ΔdnaJ::frt ΔptrB::kan P1: JW1834 (242) x AJW5619 
AJW5629 AJW678 Δcrp::frt ΔdnaJ::frt ΔglpG::kan P1: JW5687 (242) x AJW5619 
AJW5630 AJW678 Δcrp::frt ΔdnaJ::frt ΔclpB::kan P1: JW2573 (242) x AJW5619 
AJW5631 AJW678 Δcrp::frt ΔdnaJ::frt ΔycaC::kan P1: JW0880 (242) x AJW5619 
AJW5632 AJW678 Δcrp::frt ΔdnaJ::frt ΔyifB::kan P1: JW3738 (242) x AJW5619 
AJW5633 AJW678 Δcrp::frt ΔdnaJ::frt ΔycbZ::kan P1: JW0938 (242) x AJW5619 
AJW5680 AJW678 Δcrp::frt ΔdnaJ::frt ΔprlC::kan P1: JW3465 (242) x AJW5619 
AJW5740 AJW678 ΔdnaJ::kan P1: JW0014 (242) x AJW678 
AJW5784 AJW678 ΔdnaJ::frt 
removed antibiotic cassette from 
AJW5740 
AJW5792 AJW678 ΔdnaJ::frt ΔclpX::kan P1: JW0428 (242) x AJW5784 
AJW5793 AJW678 ΔdnaJ::frt ΔclpP::kan P1: JW0427 (242) x AJW5784 
AJW5794 AJW678 ΔdnaJ::frt ΔclpQ::kan P1: JW3903 (242) x AJW5784 
AJW5795 AJW678 ΔdnaJ::frt ΔclpY::kan P1: JW3902 (242) x AJW5784 
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AJW5796 AJW678 ΔdnaJ::frt Δlon::kan P1: JW0429 (242) x AJW5784 
AJW5797 AJW678 ΔdnaJ::frt ΔpepE::kan P1: JW3981 (242) x AJW5784 
AJW5798 AJW678 ΔdnaJ::frt ΔclpA::kan P1: JW0866 (242) x AJW5784 
AJW5799 AJW678 ΔdnaJ::frt ΔptrB::kan P1: JW1834 (242) x AJW5784 
AJW5800 AJW678 ΔdnaJ::frt ΔglpG::kan P1: JW5687 (242) x AJW5784 
AJW5801 AJW678 ΔdnaJ::frt ΔclpB::kan P1: JW2573 (242) x AJW5784 
AJW5802 AJW678 ΔdnaJ::frt ΔycaC::kan P1: JW0880 (242) x AJW5784 
AJW5803 AJW678 ΔdnaJ::frt ΔyifB::kan P1: JW3738 (242) x AJW5784 
AJW5804 AJW678 ΔdnaJ::frt ΔycbZ::kan P1: JW0938 (242) x AJW5784 
AJW5805 AJW678 ΔdnaJ::frt ΔclpS::kan P1: JW0865 (242) x AJW5784 
AJW5806 AJW678 ΔdnaJ::frt ΔprlC::kan P1: JW3465 (242) x AJW5784 
AJW5074 BL21(DE3) pET15b-crp pET15b-crp -> AJW4860 
   
Plasmids Description Reference/Source 
pBR322 ApR (190) 
pDCRP 
pBR322 carrying crp cloned under the control of the crp promoter, 
ApR (190) 
pDCRP-crpK100A pDCRP with K100A mutation in crp This work 
pDCRP-crpK100Q pDCRP with K100Q mutation in crp This work 
pDCRP-crpK100R pDCRP with K100R mutation in crp This work 
pDCRP-crpK101E pDCRP with K101E mutation in crp (25) 
pDCRP-crpK101A pDCRP with K101A mutation in crp This work 
pDCRP-crpK101AK100A pDCRP with K101A K100A double mutation in crp This work 
pDCRP-crpK101AK100Q pDCRP with K101A K100Q double mutation in crp This work 
pDCRP-crpK101AK100R pDCRP with K101A K100R double mutation in crp This work 
pDCRP-crpH159L pDCRP with H159L mutation in crp (240) 
pRW50 CC(-41.5) 
pRW50 carrying the E. coli melR promoter derivative with a 
consensus DNA site for CRP centered at -41.5, TetR (18) 
pRW50 CC(-61.5) 
pRW50 carrying the E. coli melR promoter derivative with a 
consensus DNA site for CRP centered at -61.5, TetR (18) 
p770-yfiQ' p770 derivative carrying yfiQ promoter, ApR This work 
pET15b-crp 
pET15b derivative carrying crp gene with IPTG-inducible promoter, 
ApR (173) 
   
Primers Sequence (5'->3') Purpose 
yfiQ' EcoRI F CCTGCGTGAAGCCCAGGCTGAATTCCAATATTGTACTGC 
Generation of EcoRI site for 
insertion into p770 
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yfiQ' HinDIII R CGATTTTGGTCGCAGTAAAGCTTCCAGTCCTCGCTG 
Generation of HinDIII site for 
insertion into p770 
K100A F GTGAAGTGGCTGAAATTTCGTACGCAAAATTTCGCCAATTGATTCAGG 
Mutagenesis of pDCRP to generate 
K100A allele 
K100A R CCTGAATCAATTGGCGAAATTTTGCGTACGAAATTTCAGCCACTTCAC 
Mutagenesis of pDCRP to generate 
K100A allele 
K100Q F GTGAAGTGGCTGAAATTTCGTACCAGAAATTTCGCCAATTGATTCAGGT 
Mutagenesis of pDCRP to generate 
K100Q allele 
K100Q R ACCTGAATCAATTGGCGAAATTTCTGGTACGAAATTTCAGCCACTTCAC 
Mutagenesis of pDCRP to generate 
K100Q allele 
K100R F GAAGTGGCTGAAATTTCGTACAGAAAATTTCGCCAATTGATTCAG 
Mutagenesis of pDCRP to generate 
K100R allele 
K100R R CTGAATCAATTGGCGAAATTTTCTGTACGAAATTTCAGCCACTTC 
Mutagenesis of pDCRP to generate 
K100R allele 
K101A F GTGAAGTGGCTGAAATTTCGTACAAAGCATTTCGCCAATTGATTCAGGT 
Mutagenesis of pDCRP to generate 
K101A allele 
K101A R ACCTGAATCAATTGGCGAAATGCTTTGTACGAAATTTCAGCCACTTCAC 
Mutagenesis of pDCRP to generate 
K101A allele 
K101A K100A F GTGGCTGAAATTTCGTACGCAGCATTTCGCCAATTGATTCAGGT 
Mutagenesis of pDCRP to generate 
K101A K100A allele 
K101A K100A R ACCTGAATCAATTGGCGAAATGCTGCGTACGAAATTTCAGCCAC 
Mutagenesis of pDCRP to generate 
K101A K100A allele 
K101A K100Q F GTGGCTGAAATTTCGTACCAGGCATTTCGCCAATTGATTCAGGT 
Mutagenesis of pDCRP to generate 
K101A K100Q allele 
K101A K100Q R ACCTGAATCAATTGGCGAAATGCCTGGTACGAAATTTCAGCCAC 
Mutagenesis of pDCRP to generate 
K101A K100Q allele 
K101A K100R F GAAGTGGCTGAAATTTCGTACAGAGCATTTCGCCAATTGATTCAGGTAAA 
Mutagenesis of pDCRP to generate 
K101A K100R allele 
K101A K100R R TTTACCTGAATCAATTGGCGAAATGCTCTGTACGAAATTTCAGCCACTTC 
Mutagenesis of pDCRP to generate 
K101A K100R allele 
q16S F CGGTGGAGCATGTGGTTTA qPCR quantification of 16S RNA 
q16S R GAAAACTTCCGTGGATGTCAAGA qPCR quantification of 16S RNA 
qCrp F TCATTGCCACATTCATAAGTACCC qPCR quantification of crp mRNA 
qCrp R TCATTTCTTTACCCTCTTCGTCTTT qPCR quantification of crp mRNA 
qFlhD F TACTACTTGCACAGCGTTTGATTGT qPCR quantification of flhD mRNA 
qFlhD R TTGTCGCCATTTCTTCATTTATGCC qPCR quantification of flhD mRNA 
qYfiQ F CGTAGTGCCTCGCGTAATAAA qPCR quantification of yfiQ mRNA 
qYfiQ R AAACCGGCACGCTGAATA qPCR quantification of yfiQ mRNA 
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CHAPTER THREE 
RESULTS 
 
Regulation of Acetylation by CRP 
 There are two known mechanisms of Nε-lysine acetylation in E. coli (which I will refer to 
as simply “acetylation” for the rest of the dissertation): 1) Enzymatic acetylation by 
acetyltransferases using acetyl-CoA as the acetyl group donor, and 2) Spontaneous non-
enzymatic acetylation using acP as the acetyl group donor. While these two mechanisms differ 
greatly in how they function and the number of lysines they target, both utilize metabolic 
intermediates as acetyl group donors. Thus, it is not surprising that there is some evidence both 
mechanisms are positively regulated by CRP, a transcriptional regulator of carbon metabolism. 
In this Chapter, I will provide additional evidence for the hypotheses that both YfiQ-dependent 
and acP-dependent acetylation are regulated by CRP. 
 
CRP-Dependent Regulation of yfiQ Transcription 
 YfiQ is the only reported lysine acetyltransferase in E. coli. Before the discovery of acP-
dependent acetylation, much work was done to identify the targets of YfiQ-dependent 
acetylation, determine the catalytic mechanism and, relevant to this dissertation, identify 
mechanisms by which cells regulate YfiQ. In silico analysis of the promoter region of the yfiQ 
gene identified several putative CRP binding sites (151). The two sites with the highest scores, 
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indicating the most likely CRP binding sites, were located at positions -41.5 and -81.5 relative to 
the TSS, suggesting the existence of both Class II and Class I binding sites. Transcription from 
the yfiQ promoter was shown to require cAMP in a concentration-dependent manner, further 
supporting regulation by CRP (151). However, there was a lack of direct evidence that CRP itself 
is required for yfiQ transcription. In this section, I will test the hypothesis that CRP regulates 
transcription of yfiQ and, if so, whether that regulation is direct or indirect. 
To determine if CRP regulates the transcription of yfiQ, with the assistance of Bozena 
Zemaitaitis, I use qRT-PCR to quantify yfiQ transcripts in ∆crp strains transformed with either 
pDCRP (AJW2313), which carries the WT crp gene driven by the native crp promoter, or pBR322 
(AJW4524) as vector control (VC) (Fig. 8A). As a negative control, I used a ∆yfiQ strain 
transformed with pBR322 (AJW5204). These strains were grown in TB7 until they reached 
stationary phase. Presence of yfiQ mRNA was detected in the strain expressing WT CRP, but not 
in the strain lacking yfiQ, as expected. In the absence of CRP, yfiQ mRNA levels were about 9% 
of those found in the strain expressing WT CRP. These data support the hypothesis that CRP is 
required for full yfiQ expression. 
 To determine precisely which activating regions are required for CRP-dependent yfiQ 
transcription, I included ∆crp strains transformed with either pDCRP-crpK101E (AJW5224) or 
pDCRP-crpH159L (AJW3660), encoding CRP variants defective in Class II and Class I transcription 
respectively, in the experiment described above (Fig. 8A). In the strain expressing the AR2 
mutant CRP K101E, yfiQ mRNA levels were about 6% of those found in the strain expressing WT 
CRP, comparable to the results seen in the absence of CRP. This suggests that a fully functional 
AR2 is required for yfiQ transcription. Unfortunately, the strain expressing the AR1 mutant CRP  
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Figure 8. Transcription of yfiQ requires CRP. (A) ∆crp strains carrying pDCRP expressing WT CRP (WT), 
pBR322 (VC), pDCRP expressing CRP H159L (AR1-), or pDCRP expressing CRP K101E (AR2-), as well as a 
∆yfiQ strain carrying pBR322 (yfiQ-) were grown in TB7 supplemented with 22 mM glucose at 37°C. 
Cells were harvested in stationary phase and subjected to qRT-PCR analysis using yfiQ-specific primers. 
Data represents the average and standard deviation of two independent experiments: one performed 
in triplicate and the other performed in singlet. All values were standardized to 16S rRNA. (B) In vitro 
transcription from the yfiQ promoter with increasing concentrations of purified CRP. Each reaction 
contains 10 nM RNAP-σ70 and 200 µM cAMP. The reactions were incubated for 15 minutes at 30°C, and 
transcripts were visualized by incorporation of 32P-labelled UTP. The figure shown here represents the 
single successful attempt with usable data. rna1 transcription served as an internal control. 
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H159L gave conflicting results. In one experiment, the strain expressing CRP H159L had about 
6% of the yfiQ transcripts found in the strain expressing WT CRP, much like the strains 
expressing CRP K101E or no CRP, suggesting both AR1 and AR2 are required for full yfiQ 
transcription. In another experiment, the strain expressing CRP H159L had almost four times 
the level of yfiQ transcripts found in the strain expressing WT CRP, suggesting AR1 is inhibitory 
to yfiQ transcription. Further work will be required to determine the requirement of AR1 for 
yfiQ transcription. However, these results support the hypothesis that at least AR2 is required 
for CRP-dependent yfiQ transcription. 
 Although CRP is required for yfiQ transcription, it is not clear if the role of CRP is direct, 
through binding to one of the putative CRP binding sites, or indirect, through regulation of 
other transcriptional regulators. Given the presence of two high quality putative CRP binding 
sites, I hypothesized that at least some of the CRP-dependent regulation of yfiQ transcription is 
direct. To test this hypothesis, I performed in vitro transcription from the yfiQ promoter using 
purified WT CRP. The yfiQ promoter (from -177 to +44) was cloned into plasmid p770 to 
generate p770-yfiQ’. Purified RNAP holoenzyme containing σ70 was added to a mixture of p770-
yfiQ’, ribonucleotides containing [32P]-labelled UTP, cAMP, and various concentrations of 
purified CRP in in vitro transcription buffer. After a 15-minute incubation at 30°C, transcripts 
were separated on an acrylamide gel and visualized using a phosphoimaging screen (Fig. 8B). 
Transcription from the yfiQ promoter only occurred in the presence of CRP, and appeared to 
reach maximal levels around 400 nM CRP. Unfortunately, after several attempts, I was unable 
to reproduce these data. The likely cause was RNase contamination, since I was unable to 
visualize transcription from the rna1 control promoter. This experiment will need to be 
61 
 
 
 
reproduced to confirm the results. However, if the initial results were correct, these data would 
support the hypothesis that at least some of the CRP-dependent regulation of yfiQ transcription 
is through direct binding of CRP to the yfiQ promoter. 
 On the basis of these results, assuming successful reproduction of the in vitro 
transcription data, I conclude that CRP directly regulates transcription of yfiQ. CRP-dependent 
regulation of yfiQ transcription requires AR2, and possibly AR1. Given what is known about the 
way CRP activates transcription (see Chapter One – cAMP Receptor Protein (CRP)), and the 
existence of both Class II and Class I putative CRP binding sites in the yfiQ promoter region, it is 
likely that at least one of these ARs is responsible for the direct regulation of yfiQ transcription 
by CRP. However, this question was not directly addressed in these studies, and additional work 
is needed to confirm this conclusion. Additionally, this work does not directly test the 
hypothesis that CRP regulates YfiQ-dependent acetylation, though this work does provide 
evidence for this hypothesis. Additional work is required to show that CRP influences the 
acetylation of YfiQ-regulated lysines. 
 
CRP-Dependent Regulation of Glucose-Induced Acetylation 
 Global acetylation is dramatically increased in E. coli grown in media containing non-
limiting concentrations of glucose compared to media alone (120, 121, 134). Excess glucose 
promotes the synthesis of the acetyl group donor acP through overflow metabolism, where the 
rate of glucose uptake and catabolism exceeds the rate at which the cell can utilize acCoA in the 
TCA cycle (see Chapter One – Overflow Metabolism). AcP is generated as an intermediate 
between acCoA and acetate (Fig. 6). Synthesis of acP is required for the increase in glucose-
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induced acetylation. CRP is also required for the increase in glucose-induced acetylation (153). 
CRP increases the rates at which glucose is consumed and acetate is produced, presumably 
increasing the rate at which acP is produced as well (185). I hypothesize that CRP regulates 
glucose-induced acetylation by promoting the synthesis of acP. In this section, I will address this 
hypothesis by determining if CRP and acP function through the same pathway to promote 
glucose-induced acetylation. 
 Epistasis analysis is a powerful tool used to determine the interactions between genes 
(186). By combining two alleles with differing phenotypic consequences (e.g. loss of acetylation 
by crp deletion and increase in acetylation by ackA deletion), it is possible to 1) determine if 
two genes function within the same pathway to regulate a phenotype, and 2) determine the 
order in which the two genes are required for the phenotype. To determine if CRP and acP 
function through the same pathway to promote glucose-induced acetylation, I began by asking 
if CRP-dependent acetylation requires synthesis of acP. I started with a strain wild-type for the 
Pta-AckA pathway (AJW2179) and its isogenic ∆ackA-pta mutant (AJW5105), which does not 
synthesize acP (Fig. 6). I next transformed each strain with either pDCRP or vector control (VC, 
pBR322). The resulting transformants were grown in TB7 supplemented with 22 mM glucose (to 
induce acetylation) and 3 mM cAMP (to overcome catabolite repression). Upon entry into 
stationary phase, samples were collected and subjected to Western immunoblot analysis using 
an anti-acetyllysine antibody (Fig. 9A). Overexpression of CRP (pDCRP) in the parental strain 
(AJW4526) resulted in an increase in global acetylation relative to the parental strain 
transformed with the VC (AJW4525). Loss of acP synthesis (∆ackA-pta transformed with VC, 
AJW5111) resulted in a decrease in global acetylation relative to the parental strain  
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Figure 9. Epistasis between CRP and acP regarding glucose-induced acetylation. (A) WT or ∆ackA-pta 
strains each transformed with pDCRP or pBR322 (VC) were grown in TB7 supplemented with 22 mM 
glucose and 3 mM cAMP (to overcome catabolite repression) at 37°C. Cells were harvested upon entry 
into stationary phase and subjected to Western immunoblot analysis using an anti-acetyllysine 
antibody. Data shows results from cultures grown in triplicate and represents two independent 
experiments. (B) Same as (A), except WT, ∆ackA, ∆crp, and ∆ackA ∆crp strains all transformed with 
pBR322 (VC) were used. 
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transformed with the VC, as expected (121). Loss of acP synthesis prevented most of the CRP-
dependent increase in global acetylation in the double mutant transformed with pDCRP 
(AJW5112). The one prominent band observed in the double mutant is likely Acs; Acs is 
approximately 72 kDa, is positively regulated by CRP, and is acetylated by YfiQ in an acetyl CoA-
dependent manner (93, 151, 187). These data suggest that acP is required for glucose-mediated 
CRP-dependent acetylation. 
 I next asked if acP-dependent acetylation requires CRP. I used the same parental strain 
as above (AJW2179) and three isogenic mutants: ∆ackA (AJW5174, which accumulates acP [Fig. 
6]), ∆crp (AJW2198), and ∆ackA ∆crp (AJW5179). Each of these strains contained the VC 
plasmid for consistency with the previous experiment. The resulting transformants were grown 
in TB7 supplemented with 22 mM glucose (to induce acetylation) and 3 mM cAMP (to 
overcome catabolite repression). Upon entry into stationary phase, samples were collected and 
subjected to Western immunoblot analysis using an anti-acetyllysine antibody (Fig. 9B). 
Accumulation of acP (∆ackA) resulted in an increase in global acetylation relative to the 
parental strain, and deletion of crp resulted in a decrease in global acetylation relative to the 
parental strain as expected. Loss of CRP caused only a minor reduction in acP-dependent 
acetylation in the double mutant. These data suggest that through the accumulation of acP, the 
cell is able to bypass the requirement of CRP for glucose-mediated acetylation. 
 Together, these data support the hypothesis that CRP promotes glucose-induced 
acetylation by promoting acP synthesis. However, the mechanism by which CRP promotes acP 
synthesis was not addressed by this work. David Christensen, another student in the lab, began 
to address the mechanism after it was clear that our projects would intersect. He discovered 
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that CRP requires both AR1 and AR2 to promote glucose-induced acetylation; mutation of 
either AR alone had little effect on global acetylation (134). Additionally, he found that glucose-
induced acetylation requires the high velocity glucose transporter PtsG, whose transcription is 
driven from a promoter with Class II and Class I CRP binding sites (134, 188, 189). 
 
Summary 
 Previous studies identified potential roles for CRP in the regulation of both YfiQ-
dependent and acP-dependent acetylation. However, these studies stopped short of directly 
linking CRP to acetylation. In this Chapter, I provided additional evidence that CRP positively 
regulates both mechanisms of acetylation. In the case of YfiQ-dependent acetylation, qRT-PCR 
analysis revealed that CRP promotes yfiQ transcription in an AR2-dependent, and possibly AR1-
dependent, manner (Fig. 8A). In vitro transcription analysis suggests that at least some of this 
CRP-dependent regulation is direct (Fig. 8B), but these results are preliminary and need to be 
verified. In the case of acP-dependent acetylation, Western immunoblot analysis using an anti-
acetyllysine antibody showed that CRP is not required for glucose-induced acetylation if acP 
levels are genetically increased (Fig. 9). This suggests the role of CRP in glucose-induced 
acetylation may be to promote acP synthesis. Further analysis done by David Christensen 
revealed that glucose-induced acetylation requires the high velocity glucose transporter PtsG, 
whose transcription is CRP-dependent (134). Taken together, these results support a hypothesis 
in which acetylation is tightly linked to carbon metabolism. As such, the acetylation of 
metabolic enzymes could be a way the cell monitors the rate of carbon metabolism, and 
represent an additional layer to the regulation of metabolic activity. 
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CHAPTER FOUR 
RESULTS 
 
Regulation of CRP by Acetylation 
 In the previous chapter, I provided evidence that both known mechanisms of 
acetylation, enzymatic and non-enzymatic, are positively regulated by CRP, either directly or 
indirectly. For the vast majority of the resultant acetylations, it is unknown how their presence 
affects the acetylated protein. However, there are examples of specific acetylations that have a 
profound impact on the acetylated protein’s activity, protein-protein interactions, or stability 
(see Chapter One – Protein Acetylation – Nε-Lysine Acetylation). Intriguingly, CRP itself can be 
acetylated on several lysines in vivo, and some of these lysines are located near residues that 
are critical for CRP function (Fig. 2). This led me to hypothesize that acetylation may play a role 
in CRP activity.  
 When a lysine becomes acetylated, the lysine’s positive charge is neutralized. In this 
Chapter, I investigated whether the positive charge of CRP K100, an acetylatable lysine, plays a 
role in CRP activity. I provide evidence that the K100 positive charge is required for full CRP 
activity at a certain class of CRP-dependent promoters. I provide additional evidence that loss 
of the K100 positive charge, which would occur upon K100 acetylation, promotes CRP activity at 
a different class of promoters. 
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The Role of the K100 Positive Charge at Class II and Class I Promoters 
 When I began this dissertation work, only two lysines within CRP had been identified as 
acetylated: K52 (135) and K100 (131). Previous work by A.J. Walker-Peddakotla, a former 
student in the lab, did not identify any significance to K52 acetylation (A.J. Walker-Peddakotla, 
unpublished data). As a result, I chose to focus on a potential role for K100 acetylation. 
Quantitative mass spectrometric analysis identified that K100 is acetylated in an acP- and 
glucose-dependent manner (121, 134). K100 is adjacent to AR2 (Fig. 2), a positively charged 
region on the surface of CRP that interacts with a negatively charged region on the RNAP α 
subunit NTD (25). This interaction is critical for activation of transcription specifically from Class 
II CRP-dependent promoters; single mutation of any of the positively charged AR2 residues to 
alanine results in 5-13 fold decreases in transcription from the semi-synthetic Class II promoter 
CC(-41.5), but no defect in transcription from the semi-synthetic Class I promoter CC(-61.5) (25). 
Mutation of K100 to alanine results in a smaller (~2-fold) decrease in transcription from CC(-
41.5), and has no effect on transcription from CC(-61.5). These data indicate that K100 also 
plays a positive, though smaller, role specifically in Class II transcription. In this section, I will 
test the hypothesis that K100 requires a positive charge to promote Class II transcription. 
 To determine if the K100 positive charge is required, I utilized plasmids pDCRP (190) and 
pRW50 CC(-41.5) (18). pDCRP is a derivative of pBR322, a multicopy plasmid, that carries the 
WT crp gene driven by the native crp promoter. pRW50 CC(-41.5) is a derivative of pRW50, a 
low copy number plasmid, which carries the semi-synthetic Class II CRP-dependent promoter 
CC(-41.5) fused to lacZ. The CC(-41.5) promoter is a semi-synthetic promoter; it consists of the 
CRP-dependent melR promoter with the portion containing the native CRP binding site replaced 
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by a consensus CRP binding site centered at position -41.5 relative to the TSS, creating a Class II 
promoter. 
I generated mutations in pDCRP that would result in substitutions within CRP at position 
100, leading to a retention (K100R) or loss (K100Q and K100A) of the positive charge. I also 
included the K101A substitution as a control, since loss of K101 results in a significant decrease 
specifically in Class II promoter activity (25). Starting with a Δlac Δcrp strain, I introduced two 
plasmids: 1) pDCRP, which carried crp alleles encoding either WT CRP or one of the K100/K101 
mutants (or pBR322 as vector control), and 2) pRW50 CC(-41.5). These strains were grown in 
TB7 supplemented with 22 mM glucose to measure β-galactosidase activity as a readout for 
CC(-41.5) promoter activity. I expected that the K100R mutant would have approximately wild-
type (WT) Class II activity, while the K100Q mutant would have decreased Class II activity, 
similar to a K100A mutant.  
First, I quantified the steady state level of each CRP mutant by western immunoblot 
analysis using an anti-CRP antibody. I found that any mutant lacking a positive charge at either 
K100 or K101 (K100A, K100Q, and K101A) was present at elevated levels relative to the WT (Fig. 
10). This difference in CRP steady state levels was investigated further and will be described 
later in this Chapter (see Chapter Five – CRP Stability).  
Despite the differences in CRP steady state levels, previously published work indicates 
that it is unlikely that these differences impact the activity of the CC(-41.5) promoter, and later, 
the CC(-61.5) promoter. These promoters are insensitive to changes in CRP concentrations 
except at very low CRP concentrations (18, 191). Both CC(-41.5) and CC(-61.5) contain 
consensus CRP binding sites. Mutation of CRP binding site within the galP1 promoter to match  
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Figure 10. Quantification of CRP steady state levels. ∆crp strains carrying both pDCRP expressing the 
indicated CRP variants and pRW50 carrying the CC(-41.5) promoter fused to lacZ were grown in TB7 
supplemented with 22 mM glucose at 37°C.  Cells were harvested at OD600 1.0 and subjected to 
Western immunoblotting using an anti-CRP antibody. Data shows average results from cultures grown 
in triplicate and represents multiple independent experiments. Error bars represent standard 
deviation. 
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the consensus sequence resulted in a 100-fold increase in the affinity of CRP for the consensus 
site over the original site (192). The addition of glucose to the media, which decreases cAMP 
synthesis and therefore the ability of CRP to bind DNA, had no effect on the activity of the 
galP1 promoter containing the consensus sequence, suggesting the concentration of cAMP 
required for CRP binding to the consensus sequence is very low. In vitro DNA binding 
experiments were in agreement that the concentration of cAMP required for CRP to bind the 
consensus sequence was below the intracellular cAMP concentration found in cells grown in 
the presence of glucose (191). Finally, the dissociation time of CRP bound to the consensus 
sequence was greater than two hours, compared to a dissociation time of about eight minutes 
for CRP bound to the non-consensus CRP binding site at the lac promoter. Taken together, the 
authors concluded that CRP is permanently anchored to the consensus site in vivo. This makes 
CRP steady state levels irrelevant in the CC(-41.5) and CC(-61.5) assays, and therefore 
normalization of the β-galactosidase activity to CRP steady state levels is unnecessary. 
Using CC(-41.5), I observed a decrease in Class II promoter activity in strains expressing 
K100A or K100Q compared to the strains expressing WT or K100R, though not to the same 
extent as the K101A control (Fig. 11). These data suggest that the K100 positive charge is 
required for efficient Class II promoter activation. 
To determine if the effect of the K100 positive charge was specific to Class II promoters, 
I performed a similar experiment using pRW50 CC(-61.5) (18). pRW50 CC(-61.5) is identical to 
pRW50 CC(-41.5), with the exception of an additional insert that shifts the center of the 
consensus CRP binding site to position -61.5 relative to the TSS, creating a Class I promoter. 
Since AR2 does not play a role at Class I promoters, and K100 is not near AR1, I did not expect  
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Figure 11. Effect of K100 positive charge on Class II promoter activity. ∆crp strains carrying both 
pDCRP expressing the indicated CRP variants and pRW50 carrying the CC(-41.5) promoter fused to lacZ 
were grown in TB7 supplemented with 22 mM glucose at 37°C. Samples were collected at the indicated 
OD600 and β-galactosidase activity was measured. Data shows average results from cultures grown in 
triplicate and represents multiple independent experiments. Error bars represent standard deviation. 
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the K100 positive charge to play a role at CC(-61.5). Indeed, there was little difference in CC(-
61.5) promoter activity between any of the CRP variants (Fig. 12), indicating that the K100 
positive charge status has no impact on Class I promoter activation. Together, these data 
suggest that the role of the K100 positive charge in transcription activation is specific for Class II 
promoters. 
 
Interaction Between K100 and RNAP α Subunit NTD 
 Given that 1) the positively charged AR2 makes contact with a negatively charged region 
on the RNAP α subunit NTD (25), 2) K100 requires a positive charge to promote Class II 
transcription (Fig. 11), and 3) K100 is positioned close to AR2 (Fig. 2), I hypothesized that K100 
may make an independent contact with the RNAP α subunit NTD to promote Class II 
transcription. To address this hypothesis, I began by determining if a functional AR2 was 
required for K100-dependent regulation of Class II transcription. I introduced the K100A, 
K100Q, and K100R mutations into a K101A mutant background within pDCRP and tested the 
ability of these mutants to activate Class II transcription from CC(-41.5). The K101A single 
mutant was used as a control for the status of K101. If K100 makes an independent contact 
with the RNAP α subunit NTD, I would expect K100-dependent regulation to occur even in the 
absence of a fully functional AR2. Promoter activity from CC(-41.5) was reduced considerably in 
the strain expressing CRP K101A compared to the strain expressing WT CRP, as expected (Fig. 
13). The CC(-41.5) activity of the K101A K100R double mutant was nearly identical to the 
activity in the K101A single mutant, consistent with previous data showing the K100R mutation 
has little effect on CC(-41.5) activity (Fig. 11). Strains expressing either the K101A K100A or  
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Figure 12. Effect of K100 positive charge on Class I promoter activity. ∆crp strains carrying both 
pDCRP expressing the indicated CRP variants and pRW50 carrying the CC(-61.5) promoter fused to lacZ 
were grown in TB7 supplemented with 22 mM glucose at 37°C. Samples were collected at the indicated 
OD600 and β-galactosidase activity was measured. Data shows average results from cultures grown in 
triplicate and represents multiple independent experiments. Error bars represent standard deviation. 
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Figure 13. Determination of the independence of the K100 positive charge from K101. ∆crp strains 
carrying both pDCRP expressing the indicated CRP variants and pRW50 carrying the CC(-41.5) promoter 
fused to lacZ were grown in TB7 supplemented with 22 mM glucose at 37°C. Samples were collected at 
the indicated OD600 and β-galactosidase activity was measured. Data shows average results from 
cultures grown in triplicate and represents multiple independent experiments. Error bars represent 
standard deviation. 
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K101A K100Q double mutants displayed a further decrease in CC(-41.5) activity over the K101A 
single mutant. These data suggest K100-dependent regulation of Class II promoter activity does 
not require that K101 be intact, and support the hypothesis that K100 may make an 
independent contact with the RNAP α subunit NTD. 
 To further investigate the potential interaction between K100 and the RNAP α subunit 
NTD, I asked if K100 is physically close enough to any negatively charged residues in the RNAP α 
subunit NTD to make an ionic interaction at a Class II promoter. I worked with Dr. Ekaterina 
Filippova in Dr. Wayne Anderson’s lab to model the interaction between CRP and RNAP at a 
Class II promoter. There are currently no crystal structures of CRP and RNAP bound at a Class II 
promoter, but there is a crystal structure of CRP and RNAP bound at a Class I promoter (176). 
This promoter consists of the Class I lac promoter, with the exception that all CRP and RNAP 
binding sequences have been replaced with consensus sequences. Dr. Filippova replaced the 
Class I promoter with the CC(-41.5) Class II promoter and adjusted the positions of CRP and 
RNAP to their relative binding sites, ensuring all of the known contacts between CRP and RNAP 
were made. The new model identified RNAP α E163 as a potential interaction partner with CRP 
K100 (Fig. 14). The model predicts an average distance of 2.75 angstroms between the CRP 
K100 ε-nitrogen atom and each of the RNAP α E163 γ-carboxyl group oxygen atoms. This value 
is well within the four angstrom range for salt bridge formation (193). These data further 
support the hypothesis that CRP K100 makes an independent contact with RNAP α, and suggest 
K100 should be considered a bona fide member of AR2. 
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Figure 14. Model of the interaction between K100 and RNAP at a Class II promoter. Top, model 
structure of the ternary complex between CRP, RNAP and Class II promoter. Bottom, closeup of the 
interactions between CRP AR2 and the RNAP α subunit at a Class II promoter. αI subunit of RNAP, σ70 
region 4 domain of RNAP, CRP dimer and DNA are shown as ribbon diagram. αII, β, β’, ω subunits and 
σ
70 non-conserved region (NCR) of RNAP are displayed as surface model. RNAP subunits are shown as 
follows: αI C-terminal domain, purple; αI N-terminal domain, dark purple; αII, gold; β, coral; β’, grey; ω, 
pink; σ70, sea green. Subunits of the CRP dimer are shown in lemon and lawn green. DNA is colored in 
magenta. Activation region AR1 of CRP at class I and class II promoter composing residues 157-160 and 
164 are colored in gold and light green, respectively. Activation regions AR2 and AR3 of CRP at class II 
promoter composing residues 19, 21, 100, 101, and 52-55, 58, respectively, are colored in gold. 
Corresponding residues of αI C-terminal, N-terminal domain, and σ70 region 4 domain of RNAP are 
colored in lilac, purple, and light blue, respectively. Non-carbon atoms of interacting residues are 
colored in red (oxygen), blue (nitrogen), and yellow (sulfur).  
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The Role of the K100 Positive Charge in Global Transcription 
 In the previous sections, I found that the K100 positive charge promotes transcription 
from the Class II promoter CC(-41.5), while having little effect on transcription from the Class I 
promoter CC(-61.5) (Fig. 11). However, these two promoters do not naturally exist in E. coli, and 
therefore do not necessarily represent the role of the K100 positive charge at all CRP-
dependent promoters. CRP activity can vary greatly depending upon the position and sequence 
of the CRP binding site, as well as presence of other promoter binding elements, that 
presumably affect the interactions between CRP and RNAP (18, 194). Additionally, the 
information gathered from CC(-41.5) and CC(-61.5) does not address the role of the K100 
positive charge in cell physiology.  
CRP Overexpression in a Complex Media 
To address these issues, I determined the effect of the K100 positive charge on global 
transcription using RNAseq analysis. I started by transforming a ∆crp strain (AJW5246) with 
pDCRP encoding the WT (AJW5248), K100Q (AJW5250), or K100R (AJW5251) CRP variants. I 
grew these strains in triplicate in TB7 supplemented with 22 mM glucose until early stationary 
phase (OD600 1.8). RNA was extracted and submitted for RNAseq analysis, performed by Gina 
Kuffel in the Loyola Genomics Facility. The RNAseq data have been deposited in NCBI's Gene 
Expression Omnibus (184) and are accessible through GEO Series accession number GSE97406 
(https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE97406). Processing and statistical 
analysis of the data was performed by Gina; I performed the analysis of the genes identified as 
differentially regulated in the pairwise comparisons between the strains expressing the WT, 
K100Q, and K100R CRP variants. I expected a general decrease in transcription of genes driven 
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by Class II CRP-dependent promoters in the strain expressing K100Q relative to the strains 
expressing either WT CRP or K100R, much like I saw at CC(-41.5) (Fig. 11). Furthermore, in 
contrast to CC(-61.5), I expected a general increase in transcription of genes driven by Class I 
CRP-dependent promoters in the strain expressing K100Q relative to the strains expressing 
either WT CRP or K100R for the following reasons: 1) endogenous CRP-dependent promoters 
do not contain consensus CRP binding sites (191), and are therefore sensitive to CRP 
concentration, and 2) strains expressing K100Q have greater CRP steady state levels than 
strains expressing WT CRP or K100R (Fig. 10), so CRP-dependent promoters should be occupied 
by CRP more often in the strain expressing K100Q relative to strains expressing WT CRP or 
K100R. 
Relative to the strain expressing WT CRP, a total of 86 and 67 genes were differentially 
expressed in the strains expressing the K100Q and K100R variants, respectively (Table 2A). 
These data support the hypothesis that K100 plays a role in regulating global transcription. 
However, I chose to focus on comparing the data between the strains expressing the 
K100Q and K100R variants, since these variants represent the complete presence or absence of 
the K100 positive charge on all CRP molecules in the cell. This is in contrast to the strain 
expressing WT CRP, which likely consists of a mixture of CRP molecules that are either 
acetylated or unacetylated on K100. Comparing strains expressing the K100Q and K100R 
variants, a total of 386 genes were differentially regulated (Table 2A). Twelve out of eighteen 
(67%) differentially regulated genes driven by Class II CRP-dependent promoters displayed 
lower expression in the K100Q mutant relative to the K100R mutant, suggesting the positive 
charge is important for increased transcription from at least a subset of Class II promoters. 
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Table 2. Number of genes and promoters whose regulation was significantly altered by the K100 charge status.
A.
QvWT RvWT QvR QvN-X RvN-X QvR-X QvN-S RvN-S QvR-S QvN-X RvN-X QvR-X QvN-S RvN-S QvR-S
Up 2 6 6 3 3 2 7 4 6 1 0 1 2 1 3
Down 2 0 12 6 14 3 2 15 1 32 6 31 16 1 36
Up 6 3 16 27 14 9 33 7 34 8 9 8 38 0 45
Down 4 1 10 7 32 4 10 67 2 25 19 25 25 0 42
Up 40 26 194 145 182 153 148 84 451 100 55 78 228 24 425
Down 32 31 148 155 267 149 128 830 25 247 241 167 256 61 486
Up 48 35 216 175 199 164 188 95 491 109 64 87 268 25 473
Down 38 32 170 168 313 156 140 912 28 304 266 223 297 62 564
Total Genes All 86 67 386 343 512 320 328 1007 519 413 330 310 565 87 1037
B.
QvWT RvWT QvR QvN-X RvN-X QvR-X QvN-S RvN-S QvR-S QvN-X RvN-X QvR-X QvN-S RvN-S QvR-S
Up 2 3 6 3 3 2 7 2 6 1 0 1 2 1 3
Down 2 0 12 4 12 3 2 11 1 23 5 21 13 1 22
Up 5 3 14 20 11 8 25 7 26 8 9 7 29 0 33
Down 4 1 9 7 25 4 6 44 2 19 18 21 16 0 26
Up 39 22 179 124 163 146 128 63 398 85 54 63 187 23 317
Down 32 27 137 145 244 138 122 661 23 222 217 151 230 58 421
Up 46 28 199 147 177 156 160 7 430 94 63 71 218 24 353
Down 38 28 158 156 281 145 130 716 26 264 240 193 259 59 469
Total Promoters All 84 56 357 303 458 301 290 723 456 358 303 264 477 83 822
a WT, Q, and R refer to ∆crp  strains expressing the WT, K100Q, and K100R CRP variants respectively from a multicopy plasmid. A gene was considered "up" or "down" if there was a statistically significant difference
in gene expression between the two strains being compared, and that difference was at least 1.5-fold.
b N, Q, and R refer to ∆crp  strains expressing the WT, K100Q, and K100R CRP variants respectively from a crp  insertion in the paaH  locus in the chromosome. A gene was considered "up" or "down" if there was a
statistically significant difference in gene expression between the two strains being compared, regardless of the magnitude of that difference.
DNA Microarrayb
TB7 + 22 mM Glucose M9 + 10 mM Glucose
Class II Regulated Genes
Class I Regulated Genes
Non-CRP Regulated Genes
Total Genes
RNAseqa
RNAseqa DNA Microarrayb
TB7 + 22 mM Glucose M9 + 10 mM Glucose M9 + 30 mM Acetate
M9 + 30 mM Acetate
Class II Promoters
Class I Promoters
Non-CRP Promoters
Total Promoters
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Sixteen out of twenty-six (62%) differentially regulated genes driven by promoters with at least 
one Class I CRP binding site, but no Class II site, exhibited increased transcription in the K100Q 
mutant relative to the K100R mutant. This implies that the positive charge of K100 does impact 
transcription of Class I genes with a tendency to decrease transcription. 
The positive charge of K100 exerted its biggest impact on transcription of genes not 
directly regulated by CRP. Relative to the K100R mutant, the K100Q mutant had a total of 194 
genes with significantly increased expression and 148 genes with significantly decreased 
expression (Table 2A). CRP is known to regulate transcription of sigma factors and other 
transcription factors (39–44); each of these could influence transcription of genes beyond direct 
CRP control. These results further support the hypothesis that the positive charge of K100 can 
impact global transcription. 
While the RNAseq data show that the CRP K100 positive charge affects the transcription 
of many genes, the data may be misleading because CRP does not regulate the transcription of 
individual genes directly; CRP regulates transcription from promoters, from which RNAP can 
transcribe multiple genes at once if these genes are organized within an operon. This could lead 
to an exaggeration of the role of the K100 positive charge; if multiple genes are regulated by 
the same CRP-dependent promoter, then alterations to CRP would affect transcription of all of 
these genes, even though only one promoter is affected. 
To address this concern, I used the EcoCyc E. coli Database (ecocyc.org) to identify the 
promoters associated with each of the differentially regulated genes. Since operons can be 
regulated by multiple promoters, I tried to assign the same promoter for each gene within an 
operon. I then assessed the number of differentially regulated promoters for each of the CRP 
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variants, with the expectation that the overall numbers would go down since multiple genes 
may have the same promoter, but that I would observe the same pattern I saw analyzing 
individual genes. 
Relative to the strain expressing WT CRP, a total of 84 and 56 promoters were 
differentially regulated in the strains expressing the K100Q and K100R variants, respectively 
(Table 2B). Comparing the strains expressing the K100Q and K100R variants, a total of 357 
promoters were differentially regulated. Twelve out of eighteen (67%) of the differentially 
regulated Class II promoters displayed decreased activity in the K100Q mutant relative to the 
K100R mutant. Fourteen out of twenty-three (61%) of the differentially regulated Class I 
promoters displayed increased activity in the K100Q mutant relative to the K100R mutant. For 
promoters not directly regulated by CRP, 179 promoters displayed increased activity and 137 
promoters displayed decreased activity in the K100Q mutant relative to the K100R mutant. 
These values are very close to those observed when analyzing individual gene expression, 
suggesting 1) many of the promoters affected by the K100 positive charge only regulate a single 
gene, 2) in many cases, only one gene within an operon was detected as differentially regulated 
by the K100 positive charge, or 3) a combination of both. Regardless, these data support the 
hypothesis that, in general, the CRP K100 positive charge promotes transcription from Class II 
promoters and reduces transcription from Class I promoters, which can influence transcription 
from promoters that are not directly CRP-dependent. 
Single Copy Chromosomal Expression of crp in Minimal Media 
 While I was analyzing global gene expression in strains overexpressing CRP K100 
acetylation mimics, we were informed that Ana Écija-Conesa from the lab of Dr. Manuel 
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Canovas was analyzing global gene expression in strains expressing CRP K100 acetylation 
mimics in single copy from the chromosome. Our labs decided to collaborate and share data. 
 To generate strains expressing CRP variants from the chromosome in single copy, Ana 
began with a ∆crp strain and used λRed recombineering (195) to replace a specific locus in the 
chromosome with the WT, K100Q, and K100R crp alleles. She was unsuccessful in replacing the 
native crp locus for unknown reasons, so she replaced the paaH locus instead. The paaH locus 
was chosen for three reasons: 1) The paa operon is not essential for E. coli growth on minimal 
media with glucose or acetate as the sole carbon source (196); 2) The paa operon is not 
expressed during growth on minimal media with glucose or acetate as the sole carbon source 
(Davis et al. in revision); and 3) The distance between the paaH and crp loci is large enough to 
avoid undesired recombination events during the gene insertion process. The newly 
recombined strain carrying the WT crp allele in place of paaH is referred to as the “N” reference 
strain, while the strains carrying the K100Q and K100R alleles are called the K100Q and K100R 
strains respectively. 
 To assess differences in global gene expression between the N, K100Q, and K100R 
strains, Ana grew these strains in minimal media with either 10 mM glucose or 30 mM acetate 
as the sole carbon source. These carbon sources were chosen to maximize or minimize global 
acetylation, respectively, including K100 acetylation in the N strain. Samples were collected in 
exponential phase (OD600 0.5) and in stationary phase (OD600 1.5) and subjected to DNA 
microarray analysis. The global gene expression data discussed in this work have been 
deposited in NCBI's Gene Expression Omnibus (184) and are accessible through GEO Series 
accession number GSE96955 
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(https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE96955). Processing and statistical 
analysis of the data was performed by members of the Canovas lab; I performed the analysis of 
the genes identified as differentially regulated in the pairwise comparisons between the N, 
K100Q, and K100R strains. 
Relative to the reference strain N expressing WT CRP, several genes were differentially 
expressed in the strains expressing the K100Q and K100R variants, depending on media and 
growth phase (Table 2A). These data support the hypothesis that K100 plays a role in regulating 
global transcription. 
 To specifically assess the importance of K100’s positive charge, I compared gene 
expression between the K100Q mutant and the K100R mutant for each growth condition (Table 
2A). Regarding Class II promoters, few genes were differentially expressed during growth on 
glucose (exponential: 2 up/3 down; stationary: 6 up/1 down). In contrast, during growth on 
acetate (both exponential [1 up/31 down] and stationary phase [3 up/36 down]), transcription 
of many genes driven by promoters with a Class II CRP binding site was reduced in the K100Q 
mutant relative to the K100R mutant. These data agree with the RNAseq and promoter fusion 
assays, supporting the hypothesis that the K100 positive charge promotes Class II transcription.  
The effect of the K100 positive charge on transcription of genes with Class I CRP binding 
sites varied, depending on the carbon source and the phase of growth (Table 2A). In stationary 
phase cultures grown in glucose, the majority of differentially regulated Class I genes displayed 
increased transcription in the K100Q mutant relative to the K100R mutant (34 up/2 down); in 
exponential phase cultures grown in acetate, the opposite was true (8 up/25 down). In the 
other two growth conditions, there was little difference between the two mutants in the 
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number of Class I genes with increased or decreased transcription (exponential glucose: 9 up/4 
down; stationary acetate: 45 up/42 down). These results support the hypothesis that the K100 
positive charge also plays a role in Class I transcription, though that role is dependent on carbon 
source and growth phase. 
As with the RNAseq data, the largest impact of the K100 positive charge was on gene 
transcription that does not depend directly on CRP (Table 2A). Regarding non-CRP genes, for 
exponential phase cells grown in glucose (153 up/149 down) and stationary phase cells grown 
in acetate (425 up/486 down), approximately half of the differentially regulated genes had 
increased transcription in the K100Q mutant relative to the K100R mutant, and half had 
decreased transcription. For stationary phase cells grown in glucose, many more genes had 
increased transcription in the K100Q mutant relative to the K100R mutant (451 up/25 down); 
for exponential phase cells grown in acetate, the opposite was true (78 up/167 down). 
Furthermore, there were many more differentially regulated genes in stationary phase for each 
carbon source [519 (491 up + 28 down) in glucose and 1037 (473 up + 564 down) in acetate] 
than in exponential phase [320 (164 up + 156 down) in glucose and 310 (87 up + 223 down) in 
acetate], suggesting the K100 positive charge may play a more significant role in stationary 
phase than in exponential phase. Taken together, the RNAseq and DNA microarray data argue 
that the K100 positive charge plays a major role in global transcription. 
As with the differentially expressed genes identified by RNAseq, I used the EcoCyc E. coli 
Database (ecocyc.org) to identify the promoters associated with each of the differentially 
regulated genes identified by DNA microarray. The number of promoters that drive 
transcription of the differentially regulated genes is less than the number of differentially 
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regulated genes in most of the conditions (compare Tables 2A and 2B), but for each condition 
the pattern of differentially regulated promoters matches the pattern of differentially regulated 
genes. These data support the hypothesis that the large number of genes differentially 
regulated by the K100 positive charge is not an artifact of measuring gene expression instead of 
promoter activity, but instead is indicative of the major role of the K100 positive charge in 
global transcription. 
 
Pathway Enrichment Analysis of K100-Regulated Genes 
RNAseq and DNA microarray analyses identified hundreds of genes that are regulated 
by the K100 positive charge under different media and growth conditions (Table 2A). I reasoned 
that because the manipulation of the K100 positive charge affected the expression of so many 
genes, the physiology of the cell would also be affected. However, because the K100 positive 
charge regulates different sets of genes under different media and growth conditions, the 
physiological consequences of K100 manipulation would also depend on media and growth 
conditions. 
To identify pathways that might be particularly affected by the K100 charge status, I 
performed a pathway enrichment analysis of the genes that were differentially regulated 
between the K100Q and K100R mutants using the Database for Annotation, Visualization, and 
Integrated Discovery (DAVID) (197, 198). 
Using either the RNAseq or microarray data, growth in glucose did not result in any 
significantly enriched pathways as measured by the Benjamini-Hochberg corrected P-values for 
multiple tests (Table 3).  
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QvR Stationary Acetate (Microarray): 
QvR Exponential Acetate (Microarray): 
QvR Stationary Glucose (Microarray): 
QvR Exponential Glucose (Microarray): 
QvR Glucose (RNAseq): 
Table 3. DAVID analysis of genes significantly altered by the K100 charge status. 
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In contrast with cultures grown in glucose, DAVID analysis did detect pathways that 
were significantly enriched during growth on acetate. From stationary phase cultures (Table 3), 
biosynthesis of amino acids, metabolic pathways, and ABC transporters were significantly 
enriched above background. Examination of the differentially regulated genes within these 
pathways identified several genes associated with the methionine/S-adenosyl-L-methionine 
(SAM) and arginine synthesis pathways whose transcription were significantly increased in the 
K100Q mutant relative to the K100R mutant and the reference strain N. However, the 
transcriptional repressors of these pathways (metJ and argR, respectively) also were highly 
upregulated. These repressors become active upon binding to SAM or arginine, respectively 
(199, 200). These results suggest that, while these pathways are highly expressed, it is likely 
that there is little flux through the pathways.  
From exponential phase cultures grown in acetate, the flagellar regulon was significantly 
enriched above background. For each gene in this regulon that was differentially regulated, its 
transcription was elevated in the K100Q mutant relative to the K100R mutant. Many of these 
genes also were upregulated in the K100Q mutant relative to the reference strain N. Taken 
together, these observations suggest the K100Q mutant may be more motile than the K100R 
mutant and the reference strain N. 
 
K100 Regulates Flagellar-Based Motility 
E. coli can use flagella to navigate their environment, either toward nutrients or away 
from repellants (201). Flagella are extremely long, flexible protein polymers that extend out of 
the cell and rotate at their base, providing thrust to propel the cell through or across a medium. 
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Regulation of the synthesis of these complex machines is similarly complex, involving three tiers 
of gene expression (202). The Class I genes (not to be confused with Class I promoters) are flhD 
and flhC, which are expressed from a single promoter and encode transcriptional activators of 
the next tier of genes. Class II genes encode structural proteins of the flagellar base and export 
machinery, as well as FliA, a sigma factor that activates transcription of the third tier of genes. 
The Class III genes encode the motor proteins and the flagellar filament. 
CRP is required for flagellar motility; it positively regulates transcription of the flhDC 
operon from a Class I promoter (203). Flagellar genes were identified as more highly expressed 
in strains expressing K100Q relative to strains expressing either WT CRP or K100R in all media 
and growth conditions tested in both the RNAseq and DNA microarray analyses (Davis et al. in 
revision). I previously observed that strains expressing CRP variants lacking a positive charge at 
position 100 displayed greater steady state levels than strains expressing WT CRP or K100R (Fig. 
10), which should increase transcription from Class I promoters in the former strains over the 
latter strains. While I did not observe this increase in transcription from the Class I promoter 
CC(-61.5) (Fig. 12), the CRP binding site at the flhDC promoter is not consensus and thus would 
likely respond to changes in CRP steady state levels (191). I hypothesized that loss of the CRP 
K100 positive charge enhances expression of flagellar genes by increasing transcription of flhDC. 
If this is the case, then there may be a similar increase in motility in strains expressing K100Q or 
K100A over strains expressing WT CRP or K100R. 
To determine if loss of the K100 positive charge promotes flhDC transcription, I 
transformed a ∆crp strain (AJW5246) with pDCRP encoding WT CRP (AJW5248), K100A 
(AJW5249), K100Q (AJW5250), or K100R (AJW5251). These strains were grown in TB 
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supplemented with 0.5% NaCl until mid-exponential phase. At this point, cells were harvested 
and subjected to qRT-PCR analysis using primers specific to flhD (Fig. 15A). The strains 
expressing WT CRP and K100R displayed approximately equivalent levels of flhD transcript. The 
strains expressing K100A and K100Q displayed about 50% more flhD transcript than the strains 
expressing either WT CRP or K100R, suggesting the loss of the K100 positive charge does 
enhance transcription of flhDC. 
To determine if the enhancement in flhDC transcription correlates with an enhancement 
in flagellar motility, I spotted the same ∆crp strains expressing the CRP variants on motility 
plates (Fig. 15B). As the cells engage in flagellar motility, the diameter of the spot increases 
equally in all directions. After 10 hours at 30°C, the diameters of the spots from strains 
expressing K100A or K100Q were about 50% greater than the spots from strains expressing WT 
CRP or K100A. These results correlate well with the quantification of flhD transcripts, 
supporting the hypothesis that loss of the CRP K100 positive charge enhances expression of 
flagellar genes, and flagellar motility, by increasing transcription of flhDC. 
 
K100 is Acetylated by AcP In Vitro 
We previously reported that CRP K100 acetylation is elevated in vivo when acP levels are 
high. This was true when we compared isogenic mutants that either accumulate acP (ackA) or 
mutants that cannot synthesize acP (pta ackA) (121) and when WT cells are grown under 
conditions that either favor high acP levels (TB7 supplemented with 22 mM glucose) or low acP 
levels (TB7 with no supplementation) (134). Taken together, these results support the 
hypothesis that acP is the acetyl donor for CRP K100. However, it is not clear if K100 is  
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Figure 15. K100-mediated regulation of motility. (A) Strains expressing WT CRP or one of the indicated 
mutants were grown at 30°C until the cultures reached OD600 ~0.5. Samples were collected for qRT-
PCR analysis using flhD-specific primers. Primers specific for 16S rRNA were used as a loading control. 
Data are representative of two experiments performed in duplicate. Error bars represent standard 
deviation. (B) (Top) Strains expressing WT CRP or one of the indicated mutants were spotted onto 
semi-solid agar plates and incubated at 30°C. After 10 hours, the diameter of each spot was quantified. 
Data are representative of two independent experiments performed with at least eight replicates. 
Error bars represent standard deviation. (Bottom) Representative image of motility plate quantified 
above. 
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acetylated by acP directly, or by an unknown acP-dependent acetyltransferase. Since other 
proteins and peptides can be acetylated directly by acP in vitro (120, 121), I expected K100 
would also be acetylated directly by acP. 
I first addressed if acP could directly acetylate CRP. I performed an in vitro acetylation 
reaction by incubating purified CRP with increasing concentrations of acP (0-12.8 mM) for 15 or 
120 minutes at 37°C, and then stopped the reaction by adding 2x sample loading buffer and 
heating the sample to 95°C. I quantified the relative increase in CRP acetylation by western 
immunoblot analysis using an anti-acetyllysine antibody. CRP acetylation increased in a time- 
and acP concentration-dependent manner. At the highest acP concentration, this resulted in a 
~2-fold increase at 15 minutes and a ~12-fold increase at 120 minutes (Fig. 16). These data 
support the hypothesis that acP can acetylate at least some lysines within CRP directly. 
I next asked specifically which CRP lysines were sensitive to acetylation by acP in vitro. 
Dr. Birgit Schilling from the Buck Institute for Research on Aging performed quantitative mass 
spectrometric analysis on purified CRP samples incubated for 15 minutes with either no acP or 
12.8 mM acP to identify acetylated lysines and to determine the relative increase in acP-
dependent acetylation of each lysine. She identified seven lysines that were acetylated in either 
sample, including K100 (Davis et al., in revision). Acetylation of K100 and K26 increased 2.1- and 
2.4-fold, respectively, in the presence of acP (Fig. 17A and 17B, Table 4). Exposure to acP 
resulted in no significant change in the acetylation of K52 or K89; the change in acetylation of 
the other lysines (K152, K166, K188) could not be quantified due to relatively weak signal, 
interferences or methionine oxidation. CRP protein level itself did not change upon acP 
incubation as determined by quantifying 23 non-acetylated peptides (Fig. 17C and Table 5).  
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Figure 16. CRP acetylation by acP in vitro. Purified CRP (10 µg) was incubated with the indicated 
concentrations of acP for either 15 or 120 minutes at 37°C. The samples were then subjected to 
Western immunoblot analysis using anti-acetyllysine antibodies, and the relative level of acetylation 
was quantified. Data are representative of two independent experiments performed in singlet.  
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Figure 17. Analysis of K100 acetylation in vitro. Purified CRP (10 µg) was incubated with or without 
12.8 mM acP for 15 minutes at 37°C. MS1 Filtering was used to quantify relative changes in the 
abundance of K100 acetylation for two incubation replicates (P1 and P2), each acquired in technical MS 
duplicates. Results for acetylated K100 showing measured peak areas are presented for acetyl peptide 
TACEVAEISYKacK in its (A) 2+ and (B) 3+ charge state. (C) CRP protein levels did not change upon acP 
incubation, as determined by monitoring 23 non‐acetylated peptides. For (A), (B), and (C), data are 
from the lone experiment performed in doublet.  
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Table 4. Quantification of increases in CRP acetylation after incubation with acP. 
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Both incubation replicates P1 and P2 which both comprised two technical MS injection replicates were quantified
peptide peak area ratios for incubations of 12.8 mM acP over 0 mM acP are formed
Peptide Transition Rank Modified Sequence Precursor Product Protein Name Protein Description Precursor Ratio P-Value Ratio P-Value log ratio P1 log ratio P2
M/Z M/Z Charge P1_12.8mM/P1_0mM P1_12.8mM/P1_0mM P2_12.8mM/P2_0mM P2_12.8mM/P2_0mM
YPSKSTLIHQGEK precursor 1 YPSKSTLIHQGEK 496.60 496.60 sp|P0ACJ8|CRP_ECOLI Catabolite gene activator OS=Escherichia coli (strain K12) 3 1.0 0.8494 0.7 0.3150 -0.0109 -0.1400
STLIHQGEKAETLY precursor 1 STLIHQGEKAETLY 530.61 530.61 sp|P0ACJ8|CRP_ECOLI Catabolite gene activator OS=Escherichia coli (strain K12) 3 1.1 0.0818 1.3 0.0039 0.0577 0.0982
AETLYYIVK precursor 1 AETLYYIVK 550.31 550.31 sp|P0ACJ8|CRP_ECOLI Catabolite gene activator OS=Escherichia coli (strain K12) 2 1.1 0.0789 0.7 0.0015 0.0453 -0.1480
GSVAVLIKDEEGK precursor 1 GSVAVLIKDEEGK 672.87 672.87 sp|P0ACJ8|CRP_ECOLI Catabolite gene activator OS=Escherichia coli (strain K12) 2 1.1 0.2311 1.4 0.1409 0.0454 0.1434
GSVAVLIKDEEGK precursor 1 GSVAVLIKDEEGK 448.92 448.92 sp|P0ACJ8|CRP_ECOLI Catabolite gene activator OS=Escherichia coli (strain K12) 3 1.2 0.0566 1.3 0.1663 0.0906 0.1057
AKTACEVAEISYK precursor 1 AKTAC[+57]EVAEISYK 735.37 735.37 sp|P0ACJ8|CRP_ECOLI Catabolite gene activator OS=Escherichia coli (strain K12) 2 1.2 0.0171 1.1 0.1690 0.0886 0.0460
AKTACEVAEISYKK precursor 1 AKTAC[+57]EVAEISYKK 533.28 533.28 sp|P0ACJ8|CRP_ECOLI Catabolite gene activator OS=Escherichia coli (strain K12) 3 1.3 0.1231 1.0 0.5204 0.1104 0.0177
AKTACEVAEISYKK precursor 1 AKTAC[+57]EVAEISYKK 400.21 400.21 sp|P0ACJ8|CRP_ECOLI Catabolite gene activator OS=Escherichia coli (strain K12) 4 1.3 0.1103 1.0 0.6200 0.1117 -0.0159
TACEVAEISYK precursor 1 TAC[+57]EVAEISYK 635.80 635.80 sp|P0ACJ8|CRP_ECOLI Catabolite gene activator OS=Escherichia coli (strain K12) 2 1.0 0.9602 1.2 0.0214 0.0019 0.0697
TACEVAEISYK precursor 1 TAC[+57]EVAEISYK 424.20 424.20 sp|P0ACJ8|CRP_ECOLI Catabolite gene activator OS=Escherichia coli (strain K12) 3 1.0 0.9797 1.2 0.1046 -0.0013 0.0622
TACEVAEISYKK precursor 1 TAC[+57]EVAEISYKK 699.85 699.85 sp|P0ACJ8|CRP_ECOLI Catabolite gene activator OS=Escherichia coli (strain K12) 2 1.2 0.0783 1.1 0.0432 0.0752 0.0291
TACEVAEISYKK precursor 1 TAC[+57]EVAEISYKK 466.90 466.90 sp|P0ACJ8|CRP_ECOLI Catabolite gene activator OS=Escherichia coli (strain K12) 3 1.2 0.0185 1.0 0.2212 0.0704 0.0149
QLIQVNPDILMR precursor 1 Q[-17]LIQVNPDILM[+16]R 719.89 719.89 sp|P0ACJ8|CRP_ECOLI Catabolite gene activator OS=Escherichia coli (strain K12) 2 1.1 0.8230 1.1 0.3774 0.0213 0.0442
LQVTSEK precursor 1 LQVTSEK 402.73 402.73 sp|P0ACJ8|CRP_ECOLI Catabolite gene activator OS=Escherichia coli (strain K12) 2 1.0 0.2315 1.3 0.0225 -0.0192 0.1012
VGNLAFLDVTGR precursor 1 VGNLAFLDVTGR 631.35 631.35 sp|P0ACJ8|CRP_ECOLI Catabolite gene activator OS=Escherichia coli (strain K12) 2 1.0 0.4261 0.7 0.0182 0.0072 -0.1254
VGNLAFLDVTGR precursor 1 VGNLAFLDVTGR 421.23 421.23 sp|P0ACJ8|CRP_ECOLI Catabolite gene activator OS=Escherichia coli (strain K12) 3 1.0 0.6801 0.7 0.0060 -0.0040 -0.1326
IAQTLLNLAK precursor 1 IAQTLLNLAK 542.84 542.84 sp|P0ACJ8|CRP_ECOLI Catabolite gene activator OS=Escherichia coli (strain K12) 2 1.1 0.0277 0.9 0.0311 0.0419 -0.0499
IAQTLLNLAK precursor 1 IAQ[+1]TLLNLAK 543.33 543.33 sp|P0ACJ8|CRP_ECOLI Catabolite gene activator OS=Escherichia coli (strain K12) 2 1.1 0.0391 0.9 0.0120 0.0470 -0.0522
IAQTLLNLAK precursor 1 IAQTLLN[+1]LAK 543.33 543.33 sp|P0ACJ8|CRP_ECOLI Catabolite gene activator OS=Escherichia coli (strain K12) 2 1.0 0.2252 1.0 0.2515 0.0062 -0.0164
QPDAMTHPDGMQIK precursor 1 Q[-17]PDAM[+16]THPDGM[+16]QIK792.35 792.35 sp|P0ACJ8|CRP_ECOLI Catabolite gene activator OS=Escherichia coli (strain K12) 2 0.8 0.0402 1.1 0.1240 -0.1161 0.0346
QEIGQIVGCSR precursor 1 Q[-17]EIGQIVGC[+57]SR 615.30 615.30 sp|P0ACJ8|CRP_ECOLI Catabolite gene activator OS=Escherichia coli (strain K12) 2 1.0 0.8367 1.2 0.0464 -0.0005 0.0619
MLEDQNLISAHGK precursor 1 M[+16]LEDQNLISAHGK 491.25 491.25 sp|P0ACJ8|CRP_ECOLI Catabolite gene activator OS=Escherichia coli (strain K12) 3 1.0 0.3835 1.0 0.2325 0.0109 0.0119
TIVVYGTR precursor 1 TIVVYGTR 454.76 454.76 sp|P0ACJ8|CRP_ECOLI Catabolite gene activator OS=Escherichia coli (strain K12) 2 1.0 0.5552 0.9 0.0316 0.0084 -0.0437
Note:  mean ratios across all non-acetylated peptides for incubation replicates P1 and P2, respectively, are formed after log transformation. Mean (log) 0.0299 0.0051
Mean (Natural) 1.07 1.01
Protein level changes in P1 = mean ratio (12.8/0 mM acP) = 1.07
Protein level changes in P2 = mean ratio (12.8/0 mM acP) = 1.01
Table 5. Quantification of increases in CRP abundance after incubation with acP. 
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These data give further support to the hypothesis that CRP K100 is sensitive to acP-dependent 
acetylation, and that this acetylation is direct. 
 
Stability of K100 and K101 Mutants 
Earlier, I observed that strains expressing CRP variants lacking a positive charge at either 
position 100 or 101 displayed greater CRP steady state levels than strains expressing CRP 
variants with a positive charge at either position (Fig. 10). One attractive hypothesis is that loss 
of either positive charge at positions 100 or 101 promote the transcription of crp via a 
combination of two modes of autoregulation: positive autoregulation from the Class I crp 
promoter (64), and negative autoregulation by promoting transcription of a divergent gene 
(yhfA) from a Class II promoter, leading to inhibition of crp transcription through steric 
hindrance (65). Loss of the K101 positive charge is known to result in defective Class II 
transcription (25), and I showed that loss of the K100 positive charge does as well (Fig. 11). 
Additionally, loss of either positive charge results in an increase in CRP steady state level (Fig. 
10), which increases transcription from at least some Class I promoters (Table 2, Fig. 15A). I 
expected that loss of either the K100 or K101 positive charges would 1) increase transcription 
from the Class I crp promoter, and/or 2) decrease transcription from the Class II yhfA promoter. 
Either outcome would result in an increase in transcription of crp.  
To determine if the loss of the CRP K100 and K101 positive charges increase crp 
transcription, I quantified crp transcript levels in each of the strains expressing the CRP variants. 
I grew ∆crp strains carrying pDCRP encoding the CRP K100 and K101 variants in TB7 
supplemented with 22 mM glucose until mid-exponential phase (OD600 ~1.0). After extracting 
97 
 
 
 
RNA from the cultures, I performed qRT-PCR using crp-specific primers. Contrary to my 
expectations, there was very little difference in crp transcript levels between strains expressing 
any of the CRP variants (Fig. 18). These data suggest that regulation of CRP steady state level by 
the K100 and K101 positive charges is not at the level of crp transcription, but somewhere 
downstream. 
One possibility is that the loss of the K100 and K101 positive charges enhance CRP 
stability, resulting in greater CRP steady state levels. This hypothesis is supported by reports 
that the stability of another protein, RNase R, is regulated by the positive charge of an 
acetylatable lysine (148, 160, 162). 
I tested the hypothesis that positive charges at positions 100 and 101 reduce CRP 
stability using a CRP stability assay. I grew ∆crp strains carrying pDCRP encoding the CRP K100 
and K101 variants in TB7 supplemented with 22 mM glucose until early-exponential phase 
(OD600 ~0.5). I used the K101E variant, which results in a reversal of the K101 positive charge, 
whose steady state levels are elevated to levels similar to the K101A variant (Fig. 10). I then 
added chloramphenicol to each culture to prevent the synthesis of new proteins. At regular 
intervals after chloramphenicol addition, I collected samples of each culture to quantify the 
relative amount of remaining CRP by western immunoblot analysis. Based on the rates of CRP 
loss, WT CRP displayed a half-life of about 107 minutes (Fig. 19A). The K100R variant was less 
stable, displaying a half-life of about 77 minutes. In contrast, the K100Q variant was 
considerably more stable, displaying a half-life of 256 minutes. The K101E mutant, which 
previously displayed the greatest steady state levels, displayed no appreciable decrease in CRP 
levels over the course of the experiment, suggesting this variant is the most stable of those  
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Figure 18. Quantification of crp mRNA. ∆crp strains carrying both pDCRP expressing the indicated CRP 
variants and pRW50 carrying the CC(-41.5) promoter fused to lacZ were grown in TB7 supplemented 
with 22 mM glucose at 37°C.  Cells were harvested at OD600 1.0 and subjected to qRT-PCR analysis 
using crp-specific primers. Data shows average results from cultures grown in triplicate and represents 
multiple independent experiments. Error bars represent standard deviation. 
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Figure 19. Stability of CRP variants. (A) ∆crp strains carrying pDCRP expressing the indicated CRP 
variants were grown in TB7 supplemented with 22 mM glucose at 37°C. At OD600 0.5, chloramphenicol 
was added to inhibit protein synthesis. At regular intervals, samples were collected for Western 
immunoblot analysis using an anti-CRP antibody. Time 0 is the timepoint at which CRP concentrations 
were greatest for each variant. Data shows average results from cultures grown in triplicate and 
represents two independent experiments, with the exception that the data from K100R represents a 
single experiment performed in triplicate. Error bars represent standard deviation. (B) A Western blot 
from (A) showing the increase in CRP K100Q concentration after chloramphenicol addition prior to the 
decrease observed due to CRP degradation. This blot is representative of the strains expressing the WT, 
K100Q, and K100R variants. 
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tested. Together, these results support the hypothesis that the positive charges at positions 100 
and 101 regulate CRP stability, and that the loss of either of these positive charges increases 
stability of the protein. 
There are a few caveats to the above experiment. First, the experiment was ended 
before the complete degradation of CRP. Without following the degradation to its endpoint, I 
only know the shape of a section of the degradation curve, which may not represent the shape 
of the full degradation curve. As a result, the best-fit line from which the half-lives were 
calculated may not be accurate in the context of the entire degradation curve. Second, there 
was an issue with the inhibition of protein synthesis. After the addition of chloramphenicol, CRP 
levels would continue to rise for a few hours before finally starting to decrease (Fig. 19B). As a 
result of this issue, I considered the 0 timepoint to be the timepoint at which CRP levels were 
greatest for each replicate and calculated the degradation curve starting from this point. Both 
of these issues need to be addressed for any future studies of CRP half-life. However, the data 
still suggest that there is some difference in the stability of the CRP variants, and these 
differences warrant further investigation into the roles of the K100 and K101 positive charges in 
CRP stability. 
 
Identification of Proteins Involved in CRP Degradation 
In the previous section, I provided evidence that loss of the CRP K100 and K101 positive 
charges enhance the stability of CRP. The simplest explanation is that these positive charges are 
required for proper CRP degradation. The positive charges may be part of a motif that is 
recognized by a protease or chaperone protein, or the positive charges may comprise a 
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protease cleavage site, similar to trypsin-like proteases, which cleave after positively charged 
lysine and arginine residues. Loss of either positive charge may change the interaction between 
CRP and the relevant protease and/or chaperone. 
The protease responsible for CRP degradation has not yet been identified. However, it 
has been reported that the chaperone protein DnaJ is required for CRP stability; loss of DnaJ 
reduces CRP half-life from >80 minutes to 3 minutes (204). The mechanism by which DnaJ 
protects CRP from degradation is not understood, but one possibility is that DnaJ interacts with 
CRP directly, shielding CRP from protease activity. If this is true, I hypothesize the CRP K100 and 
K101 positive charges are inhibitory to the DnaJ-CRP interaction. In the absence of the K100 
and K101 positive charges, for example by neutralization with an acetyl group, there would be 
increased interaction between DnaJ and CRP, greater CRP stability, and greater CRP steady 
state levels. However, in the absence of DnaJ, the DnaJ-CRP interaction no longer exists, so the 
status of the K100 and K101 positive charges should have no effect on the stability of CRP, 
leading all CRP variants to be equally unstable. 
To test this hypothesis, I generated a ∆crp ∆dnaJ double mutant strain (AJW5587) and 
transformed it with pDCRP encoding WT CRP (AJW5599), K100A (AJW5600), K100Q (AJW5601), 
K100R (AJW5602), K101A (AJW5603), or K101E (AJW5604). I grew each of these strain in TB7 
supplemented with 22 mM glucose until early exponential phase (OD600 ~0.7) and performed 
Western immunoblot analysis using an anti-CRP antibody. CRP was not detectable in the strain 
expressing WT CRP (Fig. 20A), in line with the significantly reduced stability of CRP (204). CRP 
also was not detectable in the strains expressing K100A or K100R. However, CRP was still 
readily detectable in the strains expressing K100Q, K101A, or K101E. These results suggest that  
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Figure 20. Role of K100 positive charge in DnaJ-mediated CRP stability. (A) ∆dnaJ ∆crp strains carrying 
pDCRP were grown in TB7 supplemented with 22mM glucose at 37°C until entry into stationary phase. 
The cultures were harvested and subjected to Western immunoblot analysis using an anti-CRP 
antibody. This blot is representative of two independent experiments performed in triplicate. (B) ∆dnaJ 
∆crp strains carrying pDCRP were grown in TB7 supplemented with 22mM glucose at 37°C until entry 
into stationary phase. The cultures were harvested and subjected to qRT-PCR using crp-specific 
primers. Data shows average results from sole experiment performed in triplicate.  
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the CRP variants lacking the K100 or K101 positive charge (with the exception of K100A) are 
stable even in the absence of DnaJ. 
To determine if the undetected CRP variants were still transcribed, I performed qRT-PCR 
using crp-specific primers on the samples from the above experiment. There were very low-to-
undetectable levels of crp transcript in the strains expressing WT CRP, K100A, and K100R (Fig. 
20B), consistent with the inability to detect CRP protein in these strains (Fig. 20A). These results 
are in opposition to previously published data showing that WT crp is still transcribed in a ∆dnaJ 
mutant (205). My data indicate I cannot make any conclusions regarding the role of the K100 or 
K101 positive charges in the potential DnaJ-CRP interaction, since the CRP variants with a 
positive charge at either position are not expressed in the absence of DnaJ. However, in my 
hands it appears DnaJ is required for crp transcription, and by some unknown mechanism, loss 
of either the K100 or K101 positive charge bypasses this requirement. 
Since I was unable to determine the role of the K100 and K101 positive charges on the 
potential DnaJ-CRP interaction, I tried to determine the role of the K100 and K101 positive 
charges on the interaction between CRP and the protease responsible for CRP degradation. I 
hypothesized that the increase in CRP stability in mutants lacking the K100 and K101 positive 
charges may be due to a disruption in the interaction between CRP and this protease. 
The protease that degrades CRP has not been identified, so I first attempted to identify 
this protease. To identify the protease responsible for CRP degradation, I set up a screen to 
identify mutants that were deficient in CRP degradation. I started with a ∆crp ∆dnaJ double 
mutant strain (AJW5619), since DnaJ is required for CRP stability (204). I then generated triple 
mutants by introducing deletion alleles of several genes encoding subunits of different 
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proteases. I also introduced deletion alleles of some genes encoding other chaperone proteins 
to broaden my search for proteins responsible for CRP degradation. Finally, I introduced pDCRP 
encoding WT CRP into each of the triple mutant strains. I used a ∆crp ∆dnaJ double mutant 
carrying pDCRP as a control. All of these strains will express CRP, but due to the instability of 
CRP it will be undetectable by Western immunoblot analysis. In the strains carrying a deletion 
allele for a gene involved in CRP degradation, CRP should become more stable and once again 
detectable by Western immunoblot analysis. 
To identify proteases or chaperones required for CRP degradation, I grew the above 
triple mutants carrying pDCRP in TB7 supplemented with 22 mM glucose until entry into 
stationary phase. These strains were grown at 28°C due to the temperature sensitivity of many 
of the strains. I collected samples from each culture and performed Western immunoblot 
analysis using an anti-CRP antibody. There was no detectable CRP in the ∆crp ∆dnaJ double 
mutant carrying pDCRP as expected (Fig. 21A). There was also no detectable CRP in the strain 
lacking the Lon protease, suggesting Lon is not involved in CRP degradation. However, 
detection of CRP was restored in each of the other triple mutants. These results suggest one of 
two possibilities: 1) Each one of these proteases and chaperones are required to degrade CRP 
(which is very unlikely), or 2) A suppressor mutation arose in these strains, allowing CRP to be 
stable in the absence of DnaJ. Due to the temperature-sensitive nature of many of the strains, I 
decided to change the strategy for the screen. This time I started with a ∆dnaJ single mutant, 
introduced each of the deletion alleles for proteases and chaperones, and analyzed 
endogenous CRP levels. The goal was to eliminate the need to maintain the pDCRP plasmid and 
overexpress CRP, thereby reducing the burden on the cells and decreasing the likelihood of  
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Figure 21. Determination of proteins involved in CRP degradation. (A) ∆dnaJ ∆crp strains carrying 
pDCRP and lacking the indicated genes encoding various proteases and chaperones were grown in TB7 
supplemented with 22mM glucose at 30°C until entry into stationary phase. The cultures were 
harvested and subjected to Western immunoblot analysis using an anti-CRP antibody. The experiment 
was performed once in singlet. (B) Same as (A), except ∆dnaJ strains expressing endogenous crp and 
lacking the indicated genes were used. The experiment was performed once in singlet. 
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suppressor mutations. Western immunoblot analysis of these new strains again showed that 
CRP was detectable at varying levels in every strain, this time including the ∆dnaJ single mutant 
negative control (Fig. 21B). These results suggest another suppressor mutation arose in the 
strains, stabilizing CRP. Due to the technical difficulties of the experiment, I abandoned the 
search for proteases and chaperones involved in CRP degradation. 
 
Summary 
 Acetylation is a PTM that can alter the function of the modified protein. CRP K100 has 
been identified as acetylated in numerous studies. Since K100 is adjacent to AR2, a critical 
region for CRP activity at Class II promoters, I investigated the importance of K100 acetylation 
on CRP activity. In this Chapter, I provided evidence that the K100 positive charge, which would 
be neutralized upon acetylation, was required for full CRP activity at an artificial Class II 
promoter, but not at an artificial Class I promoter (Fig. 11 and Fig. 12). The K100 positive charge 
promoted Class II promoter activity even in the absence of a functional AR2 (Fig. 13), suggesting 
K100 makes an independent contact with RNAP. Modeling the interaction between CRP and 
RNAP at a Class II promoter supported this hypothesis, highlighting RNAP α E163 as a potential 
interaction partner for CRP K100 (Fig. 14). 
 Intriguingly, loss of the K100 positive charge also increased CRP steady state levels (Fig. 
10). This was not due to an increase in crp transcription (Fig. 18), but likely due to an increase in 
CRP stability (Fig. 19). The increase in CRP steady state levels correlated with an increase in 
both transcription from the Class I flhDC promoter (Fig. 15A) and flagellar motility (Fig. 15B). I 
hypothesized the K100 positive charge was important for an interaction between CRP and an 
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unknown protease responsible for CRP degradation, but I was unsuccessful in identifying the 
unknown protease. 
 Taken together, these results suggest a model in which the acetylation of CRP K100 
directly reduces Class II promoter activity by disrupting the contact between CRP and RNAP, 
while simultaneously indirectly increasing Class I promoter activity by increasing CRP steady 
state levels and the occupancy of CRP binding sites. K100 acetylation could be a way for the cell 
to selectively enhance Class I promoter activity at the expense of Class II promoter activity 
under conditions in which acP levels are elevated. 
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CHAPTER FIVE 
DISCUSSION 
 
CRP Regulation of Acetylation 
In Chapter Three, I provided evidence that CRP positively regulates both YfiQ-mediated 
and acP-mediated acetylation. Since both mechanisms of acetylation use metabolic 
intermediates as the acetyl group donors (acCoA and acP, respectively), it is not surprising that 
CRP, a major regulator of central metabolism, is involved in their regulation. However, the 
mechanisms by which CRP regulates each method of acetylation are very different. CRP appears 
to directly promote the transcription of yfiQ (Fig. 8) (151). In contrast, the role of CRP in acP-
mediated acetylation is likely indirect, in part by increasing the rate of carbohydrate uptake, 
which promotes acP synthesis (134). Both mechanisms of acetylation could be used by the cell 
to monitor its energy status, but the two different mechanisms of CRP regulation suggest that 
YfiQ-mediated and acP-mediated acetylation monitor different aspects of the cell’s energy 
status. 
YfiQ-mediated acetylation requires acCoA as the acetyl group donor. As a result, YfiQ 
activity will be high when the cell is consuming carbon and producing significant amounts of 
acCoA. Maximal yfiQ transcription occurs: 1) when the carbon source being consumed is non-
catabolite repressing, or 2) just after the catabolite repressing carbon source is depleted (151). 
This pattern of transcription is consistent with regulation by CRP. I hypothesize that YfiQ-
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mediated acetylation senses when the cell’s energy status is high under non-catabolite 
repression conditions. In support of this hypothesis, the acetate scavenging enzyme Acs is 
inactivated by YfiQ-mediated acetylation (154). Expression of acs is induced under non-
catabolite repressing conditions by CRP (187). When acCoA levels are high, it is not necessary to 
scavenge acetate, so Acs is inactivated by YfiQ. Once acCoA levels drop, YfiQ-mediated 
acetylation decreases and CobB-mediated deacetylation restores Acs activity, enabling the 
conversion of acetate to acCoA (154). 
Much like YfiQ-mediated acetylation, acP-mediated acetylation occurs when the cell is 
consuming carbon. AcP is generated when the carbon flux through glycolysis is too high, such as 
during growth on non-limiting concentrations of glucose. I hypothesize that acP-mediated 
acetylation senses when carbon flux is too high. However, growth on glucose causes catabolite 
repression, limiting CRP activity. This means CRP must act to promote acetylation prior to acP 
accumulation. CRP promotes the expression of ptsG, which encodes the major glucose 
transporter PtsG (also called EIICB(Glc)) (188). PtsG is required for high glucose flux and acP-
mediated acetylation (134). Therefore, it is likely CRP promotes acP-mediated acetylation by 
promoting high carbon flux through expression of ptsG. These acetylations could adjust the 
activities of metabolic enzymes to accommodate the high carbon flux. Many central metabolic 
enzymes are acetylated on multiple lysines in an acP-dependent manner, suggesting acetylation 
may impact their function (121). 
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Use of K100 Acetyllysine Mimics 
The focus of Chapter Four is identifying potential effects of CRP K100 acetylation on CRP 
function and stability. One of the major difficulties in studying K100 acetylation was my inability 
to specifically acetylate K100. Until recently, it was thought acetylation required a KAT, so the 
only acetylated lysines studied were those that could be acetylated by YfiQ, the only known KAT 
in E. coli. This allowed fairly specific targeting of the lysine of interest, especially in vitro, simply 
by manipulating the presence or absence of YfiQ. In contrast with YfiQ-mediated acetylation, 
K100 appears to be non-enzymatically acetylated by acP (Fig. 16, Table 4) (121). Three issues 
complicated the specific acP-dependent acetylation of K100: 1) CRP K26 is also acetylated by 
acP (Table 4), making it difficult to attribute any acP-dependent alterations in CRP activity 
specifically to K100 acetylation; 2) At least 1309 lysines proteome-wide are acetylated in an 
acP-dependent manner (compared with 67 lysines for YfiQ) (121), making it impossible to 
specifically target CRP K100 by manipulation of acP-levels; 3) AcP also phosphorylates proteins, 
most notably response regulators (90), meaning any acP-dependent effects cannot necessarily 
even be attributed to acetylation. 
In an attempt to avoid the issues described above, my work made use of mutations that 
mimic either an unacetylated lysine (K100R) or an acetylated lysine (K100Q). These mutations 
have been used extensively to study lysine acetylation because they allow the manipulation of a 
single lysine, are simple to implement, and retain the charge status of their mimicked 
counterparts (206). However, it is important to recognize that these substitutions are not lysine 
or acetyllysine and cannot be treated as perfect mimics. For example, the acetyllysine side 
chain is considerably longer than its glutamate counterpart, thus different interactions may be 
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made between an interacting protein and the acetylated variant. In fact, there is evidence that 
substitution of lysine with glutamate may overestimate the influence of acetylation in vivo 
(207). 
A better, but considerably more complicated, method of studying K100 acetylation 
would be the use of the Schultz method to genetically encode the incorporation of acetyllysine 
at a specific site (208, 209). While the Wolfe lab has access to this powerful tool, it has yet to be 
optimized for use. This method makes use of a tRNA/tRNA synthetase pair from 
Methanosarcina barkeri. The tRNA recognizes the UAG amber codon, which is normally 
reserved as a signal to stop protein synthesis in E. coli. In M. barkeri, the tRNA synthetase 
covalently links pyrrolysine to the tRNA, and the pyrrolysine is then incorporated into nascent 
proteins when the amber codon is encountered by a ribosome. In the laboratory, this tRNA 
synthetase has been evolved many times to recognize and incorporate over 30 unnatural amino 
acids onto its cognate tRNA, including acetyllysine (209). The Schultz method is particularly 
useful for studying acetylated proteins in vitro, since one can enrich the acetylation of a specific 
lysine before purification. The major drawback of the Schultz method is the lack of a proper 
control for in vivo studies, i.e. a tRNA/tRNA synthetase pair that incorporates unacetylated 
lysine when it encounters the UAG amber codon. 
 
Function of K100 Acetylation 
I provided strong evidence that neutralization of the K100 positive charge has two 
distinct functions: 1) to decrease transcription from some CRP-dependent Class II promoters 
(Fig. 11), and 2) to increase the steady state levels of CRP (Fig. 10). A consequence of the 
112 
 
 
 
second function is an increase in transcription from some CRP-dependent Class I promoters. 
Together, these two functions provide a mechanism for the cell to inversely regulate Class II 
and Class I promoters. 
The transcriptomics analyses largely support the hypothesis that neutralization of the 
K100 positive charge decreases activity from some Class II promoters, while increasing activity 
from some Class I promoters (Table 2). Not all conditions tested follow this pattern however, 
and even under conditions that do follow the pattern there were promoters that behaved 
opposite of expectations. Several possibilities exist for why some promoters might not behave 
as expected. First, many CRP-dependent promoters are also regulated by other TFs. In some 
cases, the activities of these other TFs may overshadow the change in CRP activity due to K100 
neutralization. Second, the positioning of CRP and RNAP may not be ideal for contact between 
K100 and the RNAP alpha subunit at some Class II promoters. The position of the CRP binding 
site can deviate slightly from the ideal -41.5 position and still function as a Class II promoter 
(210, 211). This non-ideal spacing may prevent K100 from contacting the RNAP alpha subunit, 
reducing the significance of K100 neutralization. Third, CRP can act as a repressor at some 
promoters. This can occur by one of two mechanisms: 1) making too strong of an interaction 
with RNAP, overstabilizing RNAP and preventing it from escaping the promoter, or 2) steric 
hindrance. At promoters in which CRP overstabilizes RNAP, disruption of the CRP-RNAP 
interaction by K100 neutralization would increase activity from Class II promoters, and at Class I 
promoters, the increased occupancy of CRP binding sites would decrease activity from these 
promoters. At promoters in which CRP inhibits transcription through steric hindrance, K100 
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neutralization would increase the occupancy of these inhibitory binding sites, further increasing 
CRP-dependent transcription inhibition. 
DAVID analysis of genes affected by K100 neutralization identified significantly enriched 
pathways from cultures grown in the presence of acetate (Table 3). The pathways enriched 
were dependent on growth phase. Flagellar motility, which was identified in exponential phase 
cultures, will be discussed in the next section (see Chapter Five – K100 Regulates Flagellar-
Based Motility). In stationary phase, two examples of nearly complete biosynthetic pathways 
were found upregulated in the K100Q mutant, the methionine/S-adenosyl-L-methionine (SAM) 
and arginine synthesis pathways. Upregulation of the allosteric transcriptional inhibitor of each 
pathway suggests these pathways could be non-functional under these conditions. The 
expression of non-functional pathways indicates one of two possibilities: 1) K100 neutralization 
results in a need for the products of these pathways, but the cell lacks the appropriate 
precursors, or 2) K100 neutralization results in the aberrant expression of these pathways, 
wasting precious resources. These possibilities can be tested by growing the K100Q mutant in 
the presence and absence of precursors for each pathway. If the cell needs the products of the 
pathways for optimum growth, then the addition of the precursors should promote growth. If 
instead the expression of these pathways is aberrant, then the addition of precursors would not 
be beneficial and in fact may hinder growth due to the synthesis of unnecessary products. 
Either way, the results would support the hypothesis that K100 neutralization impacts cell 
physiology. 
DAVID analysis did not identify any significantly enriched pathways from cultures grown 
in the presence of glucose (Table 3). This was somewhat surprising, since the number of 
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differentially regulated genes were comparable between cultures grown in glucose and cultures 
grown in acetate (Table 2). This suggests that in the presence of glucose, the genes affected by 
the K100 charge status do not encompass entire pathways, but instead comprise small sections 
of many different pathways. This could be the result of catabolite repression, reducing the 
number of CRP-dependent genes expressed in the presence of glucose. It could also be the 
result of a difference in the sensitivities of CRP-dependent promoters to K100 neutralization, 
due to differences in the activities of other TFs between the two growth conditions. 
Since K100 acetylation is acP-dependent (Fig. 16) (121), the role of K100 acetylation 
would be most significant under conditions that favor synthesis of acP. Fermentation occurs 
through overflow metabolism when carbon flux through glycolysis exceeds carbon flux through 
the TCA cycle (90). Of the potential fermentation products, acetate (and therefore acP) is 
synthesized when the cell requires energy, since acetate is the only fermentation product 
whose synthesis produces ATP. In other words, acP is generated when the cell needs energy but 
there is too much carbon available for the TCA cycle to process. CRP is a global regulator of 
carbon metabolism, so perhaps one function of K100 acetylation is to sense that the cell needs 
energy, but is unable to acquire it through the TCA cycle and respiration. As a result, CRP diverts 
the excess carbon toward acetate fermentation. CRP enhances acP-dependent acetylation in 
the presence of excess glucose (Fig. 9), a consequence of increased acP and acetate synthesis 
(185). In this way, K100 acetylation could be a positive feedback mechanism: acP synthesis 
promotes K100 acetylation, which in turn promotes acP synthesis. It is established that acP 
promotes K100 acetylation (Fig. 16) (121), but the hypothesis that K100 acetylation promotes 
acP synthesis has yet to be tested. To address this hypothesis, the acP concentration could be 
115 
 
 
 
measured in strains expressing K100Q or K100R grown in TB7 supplemented with glucose. As a 
more indirect measure of acP production, the relative levels of global acetylation could be 
compared between strains. If K100 neutralization promotes acP synthesis, both readouts would 
be greater in the strain expressing K100Q compared to the strain expressing K100R. 
 
K100 Acetylation and Flagellar Motility 
Transcription of flhDC, which encodes the master regulator of flagellar synthesis, was 
increased in strains expressing CRP variants lacking a positive charge at position 100 (K100Q 
and K100A) relative to strains with a positive charge at position 100 (WT and K100R) (Fig. 15A, 
Table 3) (Davis et al. in revision). This increase in flhDC transcription was associated with an 
increase in flagellar motility (Fig. 15B). Together, these data strongly suggest flagellar motility 
should be enhanced under conditions in which acP levels, and therefore K100 acetylation, are 
high. Contrary to this expectation, however, flagellar motility is significantly repressed in the 
∆ackA mutant, which accumulates acP (214). This repression comes from the ability of acP to 
phosphorylate and thus activate the TCST response regulator RcsB. Phosphorylated RcsB 
directly inhibits flhDC transcription (215), while simultaneously promoting expression of genes 
required for biofilm formation, including those for colanic acid synthesis (216). If acP inhibits 
flagellar synthesis, what is the significance of the enhancement of flagellar motility by acP-
dependent K100 acetylation? 
The canonical mechanism of RcsB phosphorylation is through a phosphorelay involving 
the sensor kinase RcsC and an intermediate histidine phosphotransferase RcsD, which then 
phosphorylates RcsB (163). RcsC can also act as a phosphatase, draining phosphate groups from 
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RcsD and RcsB (217). In fact, it appears that RcsC is by default a phosphatase, and switches to a 
kinase upon receiving some environmental signal. The exact nature of the environmental signal 
is not known, but many conditions that activate the Rcs pathway and RcsB phosphorylation 
involve perturbations of the cell membrane, including osmotic shock, desiccation, and growth 
on a solid surface (218, 219). Activation of RcsB promotes the transition from attached cells to 
development of biofilm architecture; phosphorylated RcsB inhibits flagellar synthesis, motility, 
and the initial attachment to a surface (219), but is required for late-stage biofilm development 
and maturation (220). 
In contrast to RcsB, CRP activates flagellar synthesis and motility (203). While it seems 
counterintuitive, motility is required for biofilm formation (221). It is speculated that motility is 
required for the initial attachment to a surface by allowing the cells to overcome repulsive 
forces at the surface-medium interface, as well as allowing cells to spread out on the surface. 
Thus, it makes sense that CRP is required during the early stages of biofilm formation (222). 
One condition in which acP-dependent enhancement of motility may play a role is 
during biofilm formation in the gut. A combination of high glucose concentrations (0.4-24 mM) 
(223) and little oxygen (224) in the gut would promote significant acetate fermentation and acP 
synthesis. I envision a mechanism where acP contributes to biofilm formation in two steps. 
Prior to attachment, acP acetylates CRP K100, enhancing flagellar synthesis and motility to 
bring cells closer to the surface and to allow the cells to spread out across the surface. At the 
same time, acP phosphorylates RcsB, but the phosphatase activity of RcsC keeps RcsB 
phosphorylation low. Once cells are attached to the surface, RcsC switches from a phosphatase 
to a kinase, no longer antagonizing RcsB phosphorylation but instead enhancing it. 
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Phosphorylated RcsB now shuts off flagellar synthesis and promotes transcription of genes 
required for biofilm maturation.  
To test this model, a CRP K100R mutant could be used to determine if enough flagella 
could be synthesized prior to RcsB activation to generate a successful biofilm without the 
enhancement of flhDC transcription by K100 acetylation. Additionally, it would be necessary to 
examine the kinetics of acP-dependent acetylation of CRP K100, phosphorylation of RcsB by acP 
and by RcsC, and dephosphorylation of RcsB by RcsC to determine if sufficient amounts of 
acetylated CRP can accumulate to activate flagellar synthesis before sufficient amounts of 
phosphorylated RcsB can accumulate to inhibit flagellar synthesis. This experiment would be 
more difficult to interpret, since it is unclear what “sufficient amounts” of either K100 
acetylation or RcsB phosphorylation means in this context. 
 
Stoichiometry of K100 Acetylation 
The significance of K100 acetylation depends strongly on the stoichiometry of K100 
acetylation. This stoichiometry is defined as the ratio of CRP molecules acetylated on K100 
relative to total CRP molecules (137). K100 acetylation increases 7.4-fold in the presence of 
glucose relative to its absence (134) and 3.5-fold in a ∆ackA mutant that accumulates acP 
relative to its isogenic parent (121). However, since we do not know the initial or final 
stoichiometry, this information is not particularly useful in determining physiological relevance: 
in the case of acP accumulation, an increase from 0.1% to 0.35% K100 acetylation is much 
different than an increase from 20% to 70% K100 acetylation. The stoichiometry of lysine 
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acetylation on a global scale has been measured in E. coli (133, 137, 166), though none of these 
studies detected CRP K100 acetylation specifically.  
While none of the work in this dissertation directly addressed the issue of K100 
acetylation stoichiometry, there are patterns in the DNA microarray analysis that suggest a 
relatively high level of K100 acetylation in cultures grown in glucose as the sole carbon source 
and a relatively low level of K100 acetylation in cultures grown in acetate as the sole carbon 
source. In stationary phase cultures grown with glucose as the sole carbon source, the number 
of differentially regulated genes/promoters in the comparison between the N reference strain 
and K100Q was much smaller than in the comparison between the N and K100R strains (Table 
2). This indicates that the N strain is transcriptionally more similar to K100Q than K100R. The 
only difference between the three strains is the status of K100, and since the K100Q mutation 
mimics an acetylated K100, the data may be interpreted to mean that, under these conditions, 
there may be more CRP molecules acetylated at K100 than unacetylated in the N strain. 
Conversely, in stationary phase cultures grown with acetate as the sole carbon source, the 
number of differentially regulated genes/promoters in the comparison between the N and 
K100R strains was smaller than in the comparison between the N and K100Q strains. These data 
support the hypothesis that the N strain is transcriptionally more similar to K100R under these 
conditions, and that there may be more CRP molecules acetylated on K100 than not acetylated 
on K100. 
For cultures grown in glucose, the fact that the N reference strain behaves more like the 
K100Q strain than the K100R strain is not surprising. We know that glucose increases 
acetylation both globally (120, 121, 134) and specifically on K100 (121), and that acetylation 
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levels accumulate throughout growth, peaking in stationary phase (121). Therefore, we would 
expect the behavior of the N strain to gradually become more similar to the K100Q strain over 
time.  
For cultures grown in acetate, the expectations were not as obvious. Acetate was 
originally chosen as a carbon source because it is not acetogenic, so no acP should be produced 
by way of acetate formation and K100 acetylation should be minimal. However, acetate taken 
up through the Pta-AckA pathway also generates acP (Fig. 6). At high (> 10 mM) concentrations 
of acetate, cells preferential reassimilate acetate by means of the Pta-AckA pathway over the 
Acs pathway (92, 93). The 30 mM acetate used in the DNA microarray experiment would be 
sufficient to produce acP, so we might expect high levels of acetylation, contrary to the original 
goal of using acetate to minimize acetylation. In fact, global acetylation is increased in cultures 
grown on 40 mM acetate as the sole carbon source (120).  
Despite arguments for high K100 acetylation in acetate as the sole carbon source, the 
DNA microarray data suggest the stoichiometry of K100 acetylation is low under this condition. 
There are two possible reasons for the discrepancy. First, the degree of similarity between the 
N reference strain and either of the K100 mutant strains may not be a good indicator of the 
stoichiometry of K100 acetylation. The K100Q and K100R mutations may behave differently 
than acetylated and unacetylated lysines, and the transcriptional similarities between these 
strains and N may be coincidental. Second, despite high global acetylation in the presence of 
high concentrations of acetate, there may be relatively little K100 acetylation due to unknown 
KDAC activity that specifically targets K100 when acetate is present. This possibility would 
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suggest the role of K100 acetylation is dependent on more than simply the concentration of 
acP, but also the context under which that acP is formed. 
It would be interesting to repeat the DNA microarray analysis using different carbon 
sources that induce more acP synthesis than glucose or less acP synthesis than acetate to 
determine if there is a correlation between acP synthesis and the degree to which the N 
reference strain is similar to either the K100Q or K100R strains. The amount of acetate a cell 
produces is correlated with the oxidation state of the carbon source (225). A highly oxidized 
carbon source does not require the reduction of NAD+ to NADH to enter glycolysis. In fact, some 
carbon sources such as glucuronic acid must oxidize NADH to NAD+ prior to glycolysis, balancing 
the reduction of NAD+ during glycolysis. This means more carbon can be diverted to 
synthesizing ATP-generating acetate instead of synthesizing redox-balancing ethanol, lactate, or 
succinate. On the other hand, more reduced carbon sources such as sorbitol or glycerol require 
NAD+ reduction prior to entering glycolysis, further disrupting the redox balance of the cell. This 
means more of the carbon must be used to generate the redox-balancing fermentation 
products, leaving less carbon for acetate synthesis (90). 
In contrast with the DNA microarray data, expression from the Class II CC(-41.5) 
promoter in the presence of glucose suggests that the stoichiometry of K100 acetylation was 
very low. The promoter activity in the strain expressing WT CRP was indistinguishable from the 
promoter activity in the strain expressing K100R (Fig. 11), indicating the level of K100 
acetylation was not sufficient to reduce the Class II promoter activity of WT CRP. A possible 
explanation for this discrepancy is the difference in growth media between the two 
experiments. The DNA microarray experiments used a minimal defined media supplemented 
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with glucose. When glucose is the sole carbon source, cells begin consuming the glucose 
immediately. Glucose consumption correlates with an increase in global acetylation, including 
K100 acetylation (134). By the time all the glucose was consumed (i.e. in stationary phase), a 
significant amount of K100 acetylation may have accumulated. Unlike the DNA microarray 
experiments, the promoter activity assays used TB7, a buffered tryptone broth composed 
primarily of peptide fragments, supplemented with glucose. When presented with both 
tryptone and glucose, cells consume the tryptone first, and do not begin consuming glucose 
until stationary phase (212). As a result, global acetylation does not accumulate significantly 
until stationary phase (121, 134). Since the promoter assay experiments were ended just as the 
cultures were entering stationary phase, it is possible that not enough K100 acetylation had yet 
accumulated to significantly affect the Class II promoter activity of WT CRP. Thus, extending the 
promoter activity assays past the point where the cultures enter stationary phase, allowing 
K100 acetylation to accumulate, may reduce the Class II promoter activity of WT CRP to the 
point where its activity begins to resemble the activity of the K100Q mutant. 
Ultimately, the best way to determine the stoichiometry of K100 acetylation under any 
condition would be to measure it directly using previously established methods of mass 
spectrometry (133, 137, 166). These methods address an issue with traditional mass 
spectrometry, in which post-translationally modified peptides have different ionization 
efficiencies than their unmodified counterparts (137). This means values obtained for the 
modified and unmodified peptides cannot be directly compared, so stoichiometry cannot be 
determined. To overcome this issue, cell lysates containing some level of lysine acetylation are 
first incubated with labeled acetic anhydride, which chemically acetylates any unacetylated 
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lysines. Since there are no unmodified peptides, there is no discrepancy between modified and 
unmodified peptides. Mass spectrometry allows peptides acetylated by acetic anhydride to be 
distinguished from peptides acetylated endogenously based on a shift in mass equal to the 
mass of the acetic anhydride label, which varies depending on the specific method used. The 
abundance of unlabeled and labeled peptides can now be compared, and a stoichiometry value 
is obtained. It may be beneficial to first purify CRP from the cell lysates using anti-CRP 
antibodies or Ni+-affinity resin (173) to enrich signals coming from CRP peptides over peptides 
from the rest of the proteome. 
 
Acetylation of CRP K26 
In addition to CRP K100, K26 was also identified as acetylated in vitro in an acP-
dependent manner (Table 4). K26 has been identified as acetylated in previous in vivo studies 
(120, 121, 133), though its acetylation did not appear to require acP (121). The discrepancy 
between the in vitro and in vivo results regarding the acP-dependence of K26 acetylation could 
be due to one of three possibilities: 1) K26 is not acetylated by acP in vivo, and the in vitro 
results are merely an artifact of an artificial system; 2) Technical issues may have incorrectly 
identified K26 acetylation as acP-dependent in vitro or acP-independent in vivo; or 3) K26 
acetylation is acP-dependent, but KDAC activity in vivo keeps K26 acetylation low in the 
presence of acP. This last possibility is especially intriguing, because it would indicate that while 
both K100 and K26 are non-enzymatically acetylated by acP, their acetylation status is 
differentially regulated by deacetylation. However, no evidence for such a KDAC presently 
exists.  
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K26 is located in the DNA binding region of CRP. While K26 is not involved in the 
recognition of the CRP consensus sequence, it does make non-specific contacts with negatively 
charged phosphate groups in the DNA (59, 226). These contacts contribute to the bending of 
DNA around CRP. Acetylation of K26, which would neutralize the lysine’s positive charge, might 
weaken the interaction between CRP and the DNA. This would likely not have an effect on the 
recruitment of CRP to the promoter or on the interactions between CRP and RNAP, but it may 
affect transcription at CRP-dependent promoters by reducing the DNA bend angle around CRP, 
preventing distant transcriptional regulators from coming into close contact with RNAP. This 
hypothesis could be tested by measuring the DNA bend angle in vitro (61) using purified CRP 
that is specifically acetylated or unacetylated at K26 using the Schultz method (209). 
 
CRP Stability 
I provided evidence that both the K100 and K101 positive charges are important for 
proper stability of CRP (Fig. 19A). Very little is known concerning the factors that control the 
stability of CRP. The only reported regulator of CRP stability is the heat-shock chaperone 
protein DnaJ; in the absence of DnaJ, CRP stability decreases from >80 minutes to 3 minutes 
(204). However, the mechanism for DnaJ-mediated stability of CRP has not yet been 
established.  
DnaJ is a component of the DnaK/DnaJ/GrpE chaperone complex, responsible for 
protein folding de novo, refolding, disaggregation, and secretion (227). DnaJ binds stretches of 
approximately eight amino acids made up of hydrophobic (I or L), aromatic (F, W, or Y), or 
arginine (R) residues within peptides (228). DnaJ then delivers these peptides to DnaK, and 
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promotes the ATPase activity of DnaK to drive the unfolding and refolding of the target peptide. 
While DnaJ promotes CRP stability, DnaK is not required, suggesting DnaJ may work with 
multiple chaperone complexes (204). 
One possibility is that loss of either the K100 or K101 positive charge enhances the 
interaction between CRP and DnaJ, allowing DnaJ to better support CRP stabilization. There are 
a significant number hydrophobic, aromatic, and arginine residues surrounding K100 and K101 
(90-TACEVAEISYKKFRQLIQVNP-110), suggesting this region could be a recognition site for DnaJ. 
While arginines are more likely to be found within a DnaJ binding region, lysines, alanines, and 
glutamates are less likely to be found within a DnaJ binding region, and glutamines are found in 
DnaJ binding regions as frequently as in non-DnaJ binding regions (228). This indicates arginines 
likely favor DnaJ binding, while lysines, alanines, and glutamates likely disfavor DnaJ binding. 
However, this pattern of DnaJ binding is not consistent with the patterns of CRP stability 
observed when K100 or K101 is mutated to alanine, arginine, glutamate, or glutamine (Fig. 10, 
Fig. 19A). These results argue that while DnaJ may interact with the CRP region containing K100 
and K101, this interaction is probably not responsible for the observed variation in CRP stability. 
Why were some of the CRP variants not transcribed in the ∆dnaJ ∆crp pDCRP strains 
(Fig. 20)? Even though DnaJ stabilizes CRP, and CRP regulates its own transcription, loss of crp 
increases transcription from a crp-lacZ promoter fusion (66). Additionally, previous work 
showed that WT crp is still transcribed in a ∆dnaJ mutant (205), suggesting there was a problem 
with my experiment. Mutations within dnaJ prevent growth at temperatures above 42°C and 
cause slowed growth at temperatures above 30°C (229). These mutants are also genetically 
unstable, and suppressor mutations frequently arise that allow faster growth at temperatures 
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above 30°C. Generation of the ∆dnaJ ∆crp and ∆dnaJ ∆crp pDCRP strains was performed at 
37°C, so it is quite possible that suppressor mutations that prevented the expression of crp 
arose sometime during the generation of these strains. To test this hypothesis, pDCRP could be 
purified and sequenced from each of the ∆dnaJ ∆crp pDCRP strains to determine if the 
sequences have been altered. Additionally, each of the ∆dnaJ ∆crp pDCRP strains could be 
regenerated at a lower temperature to reduce the likelihood of suppressor mutations.  
 
CRP Degradation 
Changes in a CRP-DnaJ interaction are unlikely to explain the difference in stability 
between the CRP K100 and K101 mutants. Another possibility is that the K100/K101 region is 
recognized by a protease, either as a binding site or as a cleavage site, and the CRP-protease 
interaction is disrupted by loss of either the K100 or K101 positive charge. There are no reports 
indicating which protease or proteases are responsible for CRP degradation, but the fact that 
CRP variants containing positively charged residues at positions 100 or 101 are less stable than 
variants lacking a positive charge in these positions suggests a trypsin-like protease may be 
involved. Trypsin and trypsin-like proteases cleave peptides after positively charged lysine and 
arginine residues, unless they are followed by a proline (230). Post-translational modifications 
that alter the positive charge of these residues, including lysine acetylation, also prevent 
cleavage by trypsin and trypsin-like proteases (231). Acetylation of K100 or K101 could reduce 
CRP degradation by a trypsin-like protease, enhancing the stability of CRP. 
PtrB (also called Protease II or oligopeptidase B) and PrlC (also called Protease In or 
oligopeptidase A) are the two known trypsin-like proteases in E. coli (232, 233). Each protease 
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cleaves after lysine and arginine residues, though neither appears to be structurally related to 
trypsin. Interestingly, PrlC does not efficiently cleave sites containing consecutive positively 
charged residues (KK or RR) (234), while PtrB cleaves sites with consecutive positively charged 
residues more efficiently than sites with only a single positively charged residue (235). Mutation 
of either K100 or K101 to a non-positively charged residue increased the stability of the CRP 
variant, suggesting PtrB may be involved in CRP degradation. This hypothesis could be tested by 
performing an in vitro proteolytic assay using purified PtrB and each of the CRP variants to 
determine if PtrB can cleave CRP, and if the charge status of K100 or K101 contributes to the 
efficiency of this cleavage.  
 
Concluding Remarks 
 Transcriptional regulation is a complex process that integrates signals from both the 
environment and the intracellular space to ensure genes are expressed at the right time and in 
the right amounts. The work presented here provides evidence that CRP is involved in the 
production of one of these signals, Nε-lysine acetylation. This acetylation is a highly abundant 
post-translational modification in E. coli, although we are only beginning to appreciate its 
significance. Additional evidence supports the hypothesis that CRP itself is regulated by 
acetylation. Neutralization of K100 decreases CRP activity at Class II promoters, while indirectly 
increasing CRP activity at Class I promoters by increasing the CRP half-life. Transcriptomics 
analyses revealed K100 neutralization has wide-reaching effects on global transcription, 
affecting both CRP-dependent and CRP-independent genes. The work presented here highlights 
the impact a single acetylation could have on global gene expression. Dissecting the impact of 
127 
 
 
 
acetylation on the function of other transcriptional regulators will be crucial in understanding 
how the cell responds to changes in its environment. 
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